UC Davis · NPB Option A · PharmD Fall 2028 · v13 · Updated Feb 2026

PharmD Implementation Guide

Personalized roadmap verified against actual transcript, enrollment screenshots, and UC Davis catalog. MAT 017A/B/C complete. All CHE electives deferred post-application. All prereqs done by end of Spring 2027.

✓ Calculus Done MAT 017A/B/C all complete per transcript
✓ Win'26 Confirmed CHE 118B · BIS 002C · ENL 003 · CLA 035 · MGT 012Y (19 units) · ECN 001A confirmed Spr'26
Target Submit PharmCAS July–Aug 2027 · 9 schools · Matriculate Fall 2028
PharmCAS GPA at Application
3.72–3.83
Base scenario ~3.78 · Science GPA ~3.65
PharmD Acceptance Probability — by Tier
Tier 1 — Elite
UCSF · UCSD
10–35%
per school · genuine reaches
Tier 2 — Match
USC · UCI · UW · OSU
20–55%
per school · competitive
Tier 3 — Safety
UOP · WesternU · UA
50–75%
per school · near-certain
Portfolio probability (≥1 acceptance from full 9-school list): ~95%
Clinical Volunteer Target
50–80 hrs
Sum'26 · Hospital setting · Adds clinical narrative to tech experience
Pharmacy Tech Hours Target
180–200 hrs
By application (Aug '27) · 8–25 hrs/wk depending on quarter · Licensed tech = strongest differentiator
Research Hours Target
~1,000+ hrs
Franz lab · 8–12 hrs/wk ongoing · Medicinal chemistry narrative · Aim for manuscript contribution by Spr '27
Executive Summary
Who This Is For
Richard — UC Davis Year 2, NPB Option A, licensed pharmacy technician, medicinal chemistry researcher in the Franz lab, targeting Fall 2028 PharmD matriculation across 9 West Coast programs. Current confirmed GPA: 3.655 cumulative / 3.681 science after Fall 2025. Winter 2026 in progress (19 units: CHE 118B, BIS 002C, ENL 003, CLA 035, MGT 012Y). Spring 2026 enrolled (CHE 118C, PHY 007A, ECN 001A, ASA 002 — 16 units). PharmCAS application window opens July 2027.
The Strategy in One Paragraph
The NPB major and PharmD prerequisites overlap heavily but not completely. This plan front-loads all 9 pharmacy school prerequisites into Spring 2026 through Spring 2027, deliberately deferring NPB-only courses (NPB 110A/B/C, BIS 101) to Year 4 post-application. This frees pre-application quarters for high-BCPM-unit courses that move the science GPA. The Franz lab medicinal chemistry research is the single most differentiating factor in this application profile relative to a typical applicant — it must be sustained and deepened, not abandoned for GPA management.
The Numbers
Projected PharmCAS GPA at Application
3.72–3.83
Cumulative · Science GPA ~3.57–3.77
Portfolio Acceptance Probability
~95%
≥1 acceptance from full 9-school list
Per-School Range
10–75%
UCSF/UCSD (10–35%) → UOP/WesternU/UA (50–75%)
The Three Open Risks
1
Winter 2027 — Hardest Quarter
EXB 106 + BIS 103 in the same quarter is the hardest GPA stretch in the entire plan. A bad quarter here affects your science GPA at the exact moment admissions committees are evaluating trajectory — and it affects multiple schools simultaneously.
2
EXB 106 Enrollment
This course fills within hours of priority registration opening in October. Missing it cascades directly into the UCSD anatomy requirement and removes your highest-BCPM-unit quarter. Register the moment enrollment opens — no exceptions.
3
Transfer GPA Unknown
31.5 units from Mission College and Ohlone have unknown individual grades. These units apply to PharmCAS GPA calculations. Run the PharmCAS GPA estimator immediately to resolve this — it is the largest single uncertainty in the GPA model.
How to Read This Document
This document is a living strategic plan, not a checklist. It will be wrong in places — enrollment changes, grade surprises, and prerequisite updates happen. The value is in the framework and the flags, not any specific course list. When reality diverges from the plan, update the plan.
Document Structure
Executive Summary Start here. Who this is for, the strategy in one paragraph, the numbers, and the three open risks.
Quarter-by-Quarter Timeline Your primary working reference. Each card shows courses, hours commitments, and action items for that quarter. Past quarters are dimmed; current and future quarters are fully lit. Use this before every enrollment period.
GPA Tracker & Odds Running GPA projection bar with per-quarter projections. The stress test table shows how the admissions picture shifts if a hard quarter goes wrong. Check this after grades post each quarter.
Warnings & Risk Ranking Open issues ranked by their probability of causing application failure. When a warning says "verify" or "confirm," do it, then mark it resolved. The CHE 118 orgo lab verification is the only warning that can silently disqualify you — act on it first.
Prerequisite Table School-by-school verification matrix. Reference material when confirming specific requirements. Check this when a new requirement question comes up — don't memorize it.
Application Strategy Sections Personal statement architecture, LOR strategy, interview prep, financial comparison, and the 30-day action sprint. Read these when you're actively preparing for each phase — they're not meant to be read all at once.
Color Coding Reference
Timeline Card Border Colors
Red — Critical, highest-stakes quarter. Protect your GPA here above all else.
Gold — Important, action needed or significant milestone.
Teal — Steady, execute the plan.
Green — Milestone or application event.
Dimmed — Past/completed quarters.
Pill Colors (Course & Activity Tags)
Purple — NPB major course.
Orange — Science or non-NPB course (still BCPM or prereq).
Teal — Research hours (Franz lab).
Amber — Pharmacy tech hours.
Gold — Action item requiring follow-up.
How to Use It Actively
Each quarterOpen the relevant quarter card before enrollment opens. Verify every course is available, correctly sequenced, and still on track.
After grades postCheck actual grades against the GPA bar projections. If a course came in below projection, run the stress test to see the downstream effect.
On warningsWhen a warning card says "verify" or "confirm," do it immediately and mark it resolved. Do not let open verification items sit past the quarter they appear in.
On versionThis is v14. When major changes happen, update the doc rather than annotating a stale version. A stale plan gives false confidence.
What This Document Does Not Do
It does not guarantee admission. Acceptance probability bands are estimates with wide variance. Interview performance, personal statement quality, and letter of recommendation strength are not modeled here — and they carry real weight at every school, particularly at UCSF and UCSD where holistic review means a compelling narrative can outperform a marginal GPA advantage.
Quarter-by-Quarter Timeline
Legend: NPB Major Course Science (Non-NPB) Research Pharmacy Hours Action Item
Projected PharmCAS GPA — Cumulative & Science (BCPM)  based on verified transcript + per-course grade projections · see scenario table below
Cumulative GPA
Science GPA (BCPM)
Now
3.655
Now
3.681
UC Davis GPA after Fall 2025. PharmCAS recalculates including transfer units — see scenario table.
End Win'26
~3.74
End Win'26
~3.58
Key grades: CHE 118B → B+ (base) · A- (upside) · B (downside risk)  |  BIS 002C (5 BCPM units) → A- (base)  ·  9 BCPM units this quarter · ENL 003 satisfies English prereq #1 · MGT 012Y ≠ ECN 001A — econ prereq still unresolved
End Spr'26
~3.73
End Spr'26
~3.57
Target: CHE 118C → B+ · PHY 007A → A- · ECN 001A → A · ASA 002 → A  ·  PSC 001 moved to Fal'26
End Fal'26
~3.72
End Fal'26
~3.52
Target: NPB 101 → A- · BIS 102 → B+ · PHY 007B → B+ · SOC 001 → A  ·  NPB 101 is 5 BCPM units — push for A-
End Win'27
~3.73
End Win'27
~3.56
Target: EXB 106 → A- · EXB 106L → A-/A · BIS 103 → B+ · NPB 110C → A · UWP 104F → A  ·  7 combined BCPM units — largest single-quarter opportunity
End Spr'27
~3.77
End Spr'27
~3.66
Target: MMG 102 → A · CMN 001 → A · NPB 101L → A-/A · GE Humanities → A
App GPA
3.72–3.83
App Sci
3.57–3.77
UCSD min: 3.0 cum / 2.8 sci  ·  UCSF min: 2.80  ·  Competitive range ≥3.5 sci  ·  Base single estimate: ~3.78 cum / ~3.65 sci
GPA Scenario Matrix at Application (after Spring 2027 · 170.5 total units · 99 BCPM units)
Scenario Transfer Avg Grade Performance Cumulative GPA Science GPA
Conservative 3.7 B across BCPM 3.72 3.57
Base (most likely) 3.7 B+ / A- mix 3.77 3.66
Optimistic 4.0 A- across BCPM 3.89 3.81
4 courses move the needle most: CHE 118B (in progress, 4 BCPM units) · NPB 101 (Fal'26, 5 units) · EXB 106+106L (Win'27, 7 units combined) · PHY 007A (Spr'26, 4 units). Getting A- vs B+ across all four adds ~+0.08 to science GPA.
How Pharmacy Schools Interpret GPA — and Your Admission Odds
Part 1 — How Pharmacy Schools Read Your GPA
PharmCAS Recalculation
Every CA PharmD program receives your GPA not from your UC Davis transcript but from PharmCAS, which recalculates from scratch using every graded course from every institution ever attended. For this plan, that includes UC Davis, Mission College (~18 units), and Ohlone (~13.5 units). The projected 3.74 baseline assumes all transfer grades were A's — if any were B's, the PharmCAS cumulative is lower than shown. Sensitivity check: if average transfer GPA across Mission College and Ohlone was 3.5 rather than 4.0, projected cumulative drops to approximately 3.68–3.70. AP credit is excluded entirely. P-grade courses are excluded from both numerator and denominator. Run the PharmCAS GPA estimator at help.liaisonedu.com before submitting any application.
Cumulative vs. Science GPA (BCPM)
Admissions committees look at two separate figures. Cumulative GPA covers every graded course. Science GPA (BCPM) covers Biology, Chemistry, Physics, and Math only — no psychology, economics, statistics, writing, or social science. This matters here because the hardest courses in the plan (BIS 102, BIS 103, NPB 101, EXB 106, CHE 135) are all BCPM. Every B in a BCPM course moves the science GPA more than the same B would move the cumulative. The two numbers will diverge — and UCSD and UCSF both screen on science GPA independently. Note: final BCPM classification is determined by PharmCAS course audit and can differ from how UC Davis categorizes a course — some statistics and neuroscience courses have been reclassified in past audits.
Trajectory Matters as Much as the Number
UCSF and UCSD train their readers to evaluate trend, not just the final GPA. A 3.70 applicant who went 3.55 → 3.62 → 3.70 reads very differently from one who went 3.80 → 3.72 → 3.70. This student's trajectory is favorable entering the plan. The risk is that the two hardest quarters (Fall 2026 BIS 102/NPB 101, Winter 2027 EXB 106/BIS 103/CHE 135) land mid-plan and could flatten or dip the trend line at exactly the point admissions is reviewing the transcript.
Holistic Factors That Adjust the GPA Weight
At UCSF and UCSD, GPA above ~3.5 is largely a screen, not a rank. Once past the threshold, pharmacy experience, research, and personal statement carry real comparative weight. A 3.70 applicant with 200 hours pharmacy experience and a Franz lab manuscript in preparation is meaningfully more competitive than a 3.70 applicant with no research. At UOP and WesternU, GPA does more direct sorting because holistic review is less granular. The research background from Franz lab is the single most differentiating factor in this profile relative to a typical applicant.
Part 2 — Why the Header Card Said 70–80% and Why That Was Wrong
The original overview card showed 70–80% labeled as "UCSF, UCSD, UCI, USC target." This figure was inaccurate in two ways. First, it conflated the portfolio probability (at least one acceptance across all schools) with the per-school probability — a reader naturally interprets it as individual odds at each named school, which is not what the data supports. UCSF individually is 14–20%. UCSD is 20–30%. Neither clears 40%. Second, a 70–80% portfolio probability only holds if the safety schools (UOP, WesternU) are included in the denominator — but those weren't listed. The corrected figure is 85–90% for at least one acceptance including safeties. The header card has been updated to reflect this.
Part 3 — Per-School Admission Probability at Projected GPA 3.70–3.74 / Sci ≥3.58
Assumptions: 180–200 pharmacy hours, active Franz lab research, strong personal statement, 3 solid rec letters. These are directional estimates, not actuarial models. Year-to-year variation in applicant pool quality, yield behavior, and seat adjustments means actual odds can shift 5–10 points in either direction. Bands are intentionally wide to reflect execution variance — the lower end assumes average interview performance and LORs; the upper end assumes optimal execution across all dimensions. A single weak dimension (poor interview, thin rec letters, underdeveloped research narrative) tends to affect multiple schools simultaneously, not independently.
School Tier Interview Invite Post-Interview Accept Overall Prob. Key Factor
UCSF Reach 30–50% 25–45% 10–25% Research differentiates. ~300 invites for ~120 seats. Holistic after GPA screen. Assumes optimal execution — weak LORs or interview drops this further. Genuine reach.
UCSD Reach 50–65% 30–50% 15–35% More quantitative at screen stage. Science GPA matters heavily — below 3.55 materially reduces odds. GPA clears threshold comfortably at projection. ~100 seats, competitive pool.
USC Match 55–70% 35–55% 20–40% Avg admitted ~3.5. Weights leadership + community. Upper-div biochem (BIS 102) specifically required ✓.
UCI Match 60–75% 40–60% 25–45% Newer program, still building class profile median. This applicant is in their upper quartile.
UOP (Pacific) Safety 75–85% 60–75% 50–65% Avg admitted ~3.4. This profile well above median. Physics + lab required ✓. Strong safety.
WesternU Safety 80–90% 60–75% 55–70% GPA, hours, and research all exceed competitive range. Near-certain acceptance if interview obtained. Verify prereqs annually — requirements have fluctuated.
OUT-OF-STATE — Pacific Northwest & Southwest
UW (Seattle) Match 55–65% 40–55% 25–35% 93% residency match rate (Class 2025). Rotates at UW Med Center + Seattle Cancer Care. Best out-of-state option for CA return. Out-of-state tuition; no auto scholarship.
OSU (Corvallis) Match 65–75% 50–65% 35–50% 96.2% NAPLEX — #5 nationally 2024. Avg admitted sci GPA ~3.2. $19k/yr auto tuition scholarship for non-residents ≥3.0 GPA ✓. Best value in list.
U Arizona (Tucson) Safety 75–85% 60–75% 50–65% NIH funding rank #3 nationally. Consistently above-avg NAPLEX. Preferred GPA 2.75+; 3.70 is well above median. Rolling admissions. Most accessible out-of-state safety.
Loma Linda Conditional High if aligned Varies Faith-based GPA easily clears bar. Only apply if genuinely aligned with mission. Character + service weighted heavily. Prereq leniency is broadly true but verify annually before relying on it.
Part 4 — Portfolio Probability by Tier (9-School List)
Tier 1 — Elite Reaches
UCSF · UCSD
10–35%
Per school. Wide band reflects execution variance. Genuine reaches regardless.
≥1 from this tier: ~35–50%
Tier 2 — Match
USC · UCI · UW · OSU
20–55%
Per school. USC/UCI higher end; UW competitive; OSU most accessible in tier.
≥1 from this tier: ~75–85%
Tier 3 — Safety
UOP · WesternU · UA (AZ)
50–75%
Per school. Near-certain acceptance at ≥1 safety if all applied. UA most accessible.
≥1 from this tier: ~97%
Portfolio math — and its limits: A purely independent-probability model across all 9 schools gives a theoretical ~95% chance of at least one acceptance. That number is an upper bound, not a central estimate. School decisions are not statistically independent — if your application has a systematic weakness (thin personal statement, mediocre interview, underdeveloped research narrative, soft rec letters), it tends to affect multiple schools simultaneously rather than failing independently at each one. A realistic portfolio probability for a well-executed application across all 9 schools is high — treat it as very likely rather than near-certain. The safety schools (UOP, WesternU, UA) carry most of the floor. The Tier 1 and Tier 2 schools are the upside. Do not confuse portfolio probability with individual school odds — UCSF is still a low-probability shot regardless of how many other schools are on the list.
Honest assessment: UCSF and UCSD are genuine reaches. The most likely path to a top-tier acceptance runs through USC, UCSD, or UW. OSU is the strongest value proposition in the list — better NAPLEX outcomes than any CA private school, automatic tuition scholarship for non-residents. The Franz lab research background is the single biggest differentiator relative to a typical 3.70 applicant — anchor it in every personal statement. Apply to all 9 schools. Do not apply to only 2–3 schools assuming GPA makes admission likely — it does not work that way at this tier.
GPA Stress Test — What Happens If a Quarter Goes Wrong
The projected GPA of 3.70–3.74 cumulative / ~3.60 science assumes B+ or better in BIS 102, BIS 103, NPB 101, and EXB 106. Winter 2027 (EXB 106 + BIS 103 + CHE 135) is the single highest-risk quarter in the plan — three BCPM courses simultaneously, each conceptually dense. The table below shows how the admissions picture shifts under three scenarios.
Scenario Est. Cumul GPA Est. Sci GPA UCSF/UCSD USC/UCI/UW OSU/UOP/WesternU/UA Recommended Response
✓ On Track
B+ or better in all hard courses. No BCPM course below B+.
 3.70–3.74 ~3.58–3.65 Reach — credible Match — strong Safety — near-certain Apply all 9 as planned. UCSF/UCSD worth applying.
⚠ One Bad Quarter
Two B's in Winter 2027 (e.g., B in EXB 106 + B in BIS 103). One B in Fall 2026.
 3.62–3.67 ~3.48–3.55 Reach → long shot
UCSD: below 3.5 sci GPA materially weakens screening probability — no published hard cutoff, but risk is real		 Match → competitive reach
USC/UCI still viable; UW tighter		 Safety — unaffected Add 1–2 more safeties (Touro, CNUCOP). Still apply UCSF/UCSD but recalibrate expectations. Pharmacy hours to 250+ compensates partially.
✗ Rough Stretch
B or B– across multiple BCPM courses in Fall 2026 and Winter 2027 combined.
 3.52–3.60 ~3.38–3.48 Below screen threshold
UCSF/UCSD: not competitive		 USC/UCI: marginal reach
UW: likely below competitive range		 Safety — still viable Consider delaying application 1 year. Use gap year to complete post-bacc BCPM coursework, push sci GPA above 3.5. Apply cycle after with demonstrably improved trend. Pharmacy hours to 400+ range. Skip UCSF/UCSD in second cycle unless sci GPA recovers to ≥3.55.
If You Hit Scenario 2 (One Bad Quarter)
Don't panic and don't drop the application cycle automatically. A 3.62 cumulative with a strong upward trend, 200+ pharmacy hours, and active research is still a competitive application at USC, UCI, OSU, and the safety schools. Add Touro CA and CNUCOP as additional safeties to widen the floor. Write a trajectory narrative in your personal statement that acknowledges the hard quarter and frames what you learned. This is more honest and more effective than hoping committees don't notice.
If You Hit Scenario 3 (Rough Stretch)
The decision point is in Spring 2027 before applications open. If science GPA is trending below 3.45 at that point, delaying one year is almost always the right call. Apply the extra year to: targeted post-bacc upper-div science courses (4–6 units of strong grades does a lot at this level), pharmacy hours to 400+, and a rewritten personal statement with a concrete "what changed" arc. A 3.70/3.55 reapplicant with a clear improvement story is more competitive than a first-time applicant at 3.60/3.42.
Second-Order Risk — Academic Decline Cascades: A difficult Winter 2027 does not only affect GPA. The same quarter that produces B's in EXB 106 and BIS 103 also compresses research hours in Franz lab, strains the faculty relationships needed for strong letters of recommendation, and can affect interview confidence and personal statement tone during application season. These effects are correlated, not independent — a single bad quarter can weaken multiple application dimensions simultaneously. The practical implication: GPA protection is not just about the number. It preserves the surrounding ecosystem of the application. If Winter 2027 starts going wrong, triage early — reduce lab hours temporarily if needed to protect grades, then restore research bandwidth in Spring 2027.
Why the Timeline Is Arranged This Way — Prerequisite Logic
The course sequencing in this plan is the result of comparing NPB major requirements against actual PharmD admission prerequisites at every California pharmacy school. The key insight: NPB 110A/B/C and BIS 101 are not PharmD prerequisites at any school — they are NPB major requirements only. Moving them post-application (Fall 2027–Spring 2028) removes 3–4 courses from the pre-application window and fixes the previous Fall 2026 overload problem.
California PharmD Programs — Prerequisites Verified (Sources: school admissions pages, fetched Feb 2026)
School Physiology Anatomy Biochem Cell/Mol Bio Micro Physics Key Notes
UCSF ✓ Required — — — — — 19-unit behavioral sci total. Anatomy strongly preferred. Uses approved course list — verify CHE 118 satisfies orgo lab.
UCSD ✓ + lab 1 of 3† 1 of 3† ✓ + lab 1 of 3† ✓ † Must complete 1 of: Anatomy, Microbiology, or Biochemistry (+lab). BIS 102 or MMG 102 can fill this slot — EXB 106 is one option, not the only one. Min GPA 3.0 cumulative / 2.8 science.
USC ✓ — ✓ upper-div — ✓ rec. Biochemistry must be upper-division at a 4-year institution — BIS 102 at UC Davis satisfies this. Physics recommended, not required. Min GPA 3.0.
UOP (Pacific) ✓ + lab — — — ✓ ✓ + lab No bachelor's required. Physics + lab required (unusual). 68 semester units minimum. Min GPA 2.7.
Loma Linda rec. — rec. — rec. ✓ + lab Most lenient science prereqs in CA. Physiology NOT required — only recommended. Requires Gen Bio + Chem + Orgo + Physics only. Faith-based institution. Min GPA 2.75 preferred.
WesternU ✓ — ✓ — ✓ ✓ Verify current requirements at westernu.edu — confirms via prerequisite database tool.
Cal Northstate, Keck, CHSU ✓ varies 1 req. — ✓ varies Sacramento / Central Valley options. Lower competitiveness — good safety schools. Verify directly via PharmCAS School Directory.
NPB Course Classification — PharmD Prereq vs. Major Req Only
Course NPB Major Req? PharmD Prereq? Timing Rationale
NPB 101 ✓ ✓ Physiology Fall 2026 Satisfies physiology req at UCSF, UCSD, USC, UOP, WesternU. Must be pre-matriculation (July 2028).
NPB 101L ✓ (lab req) Lab component Fall 2027 UCSD + UOP require physiology lab. Moved to Fall 2027 (post-app) — must be done before July 2028 matriculation. Still pairs well after NPB 101.
NPB 110A ✓ ✗ None Spr'27 or later No PharmD program in CA requires this. Pure NPB major req. Freed from Fall 2026 to reduce overload.
NPB 110B ✓ ✗ None Fall 2027 Must follow NPB 110A. Moved post-application — no admissions impact.
NPB 110C ✓ ✗ None Win 2028 Must follow 110A+B. Completion required before degree conferral, not before PharmD application.
BIS 101 ✓ ✗ None Fall 2027 No CA PharmD program requires genetics as a standalone prereq. NPB major req only. Removed from Fall 2026 to prevent overload.
UCSD "Anatomy / Microbiology / Biochemistry" Slot — Built-In Redundancy
UCSD requires one course from: Anatomy OR Microbiology OR Biochemistry (with lab). This plan covers all three options: BIS 102 (Biochemistry, Fall 2026), EXB 106/106L (Anatomy, Winter 2027), and MMG 102 (Microbiology, Spring 2027). If any one of these courses fails to enroll or cannot be verified as equivalent, one of the other two will still satisfy the UCSD slot. This eliminates EXB 106 as a single point of failure for UCSD eligibility.
Timeline rules used throughout this plan: (1) True PharmD prerequisites land before the August 2027 application. (2) NPB major-only courses land after application (Fall 2027–Spring 2028). (3) BIS 102 always precedes BIS 103 by at least one quarter. (4) EXB 106 must precede EXB 106L (concurrent acceptable). (5) NPB 110 sequence (A→B→C) maintains order across years. (6) NPB 101L can be taken concurrent with or after NPB 101 — placed Fall 2027 to avoid pre-app overload.
Fal 2024
Year 1 · Q1

Year 1 — Foundation

COMPLETED ✓
CHE 118A (Organic Chemistry I, 4 units) ★ PharmD prereq · Grade: B+ MAT 017B (Calculus, 4 units) · Grade: B Additional Year 1 coursework

First year at UC Davis.

CHE 118A and MAT 017B are the key BCPM courses from this period. MAT 017B (B, 3.0) and CHE 118A (B+, 3.3) are the two primary BCPM drag points identified in the GPA model.

Transfer units from Mission College and Ohlone (31.5 units total) also apply — individual transfer grades remain the largest GPA uncertainty for PharmCAS.

Win 2025
Year 1 · Q2

Year 1 — Continued

COMPLETED ✓
CHE 118B (Organic Chemistry II, 4 units) ★ PharmD prereq Additional Winter coursework

Continued Year 1 coursework at UC Davis.

Spr 2025
Year 1 · Q3

Year 1 — End of Freshman Year

COMPLETED ✓
Spring 2025 coursework

End of Year 1 at UC Davis. Confirmed UC Davis GPA after Fall 2025: 3.655 (includes coursework through this point).

Sum 2025
Between Y1–Y2

Summer — Pharmacy Tech Work

COMPLETED ✓
Pharmacy technician hours (licensed)

Licensed pharmacy technician work. Building hours toward the 180–200 total target by application.

Fal 2025
Year 2 · Q1

Year 2 — Fall Quarter

COMPLETED ✓
Fall 2025 coursework Pharmacy tech hours ongoing

Confirmed UC Davis cumulative GPA after this quarter: 3.655. BCPM: 37 units, 136.2 quality points, 3.681 science GPA.

Key BCPM drag points identified: MAT 017B (B, 3.0) and CHE 118A (B+, 3.3).

Win 2026
Year 2 · Q2

Year 2 — Winter Quarter

IN PROGRESS ◎
CHE 118B (Organic Chemistry II, 4 units) ★ PharmD prereq · BCPM BIS 002C (Intro Biology: Biodiversity, 5 units) · BCPM ENL 003 (Intro to Literature, 4 units) — satisfies English prereq #1 CLA 035 (Food & Wine in the Ancient Mediterranean, 3 units) — GE MGT 012Y (Navigating Life's Financial Decisions, 3 units) — GE Pharmacy tech hours ongoing

Final confirmed schedule: 5 courses, 19 units.

CHE 118B and BIS 002C are both BCPM — 9 BCPM units this quarter.

ENL 003 satisfies English prereq #1 for UCSF and UCSD (2 English courses required total).

MGT 012Y covers personal finance; confirm with UCSF whether it satisfies the Economics component of the behavioral science block, or whether ECN 001A (confirmed Spr'26) is the definitive economics course.

Spr 2026
Year 2 → 3

Launch Phase — Right Now

ENROLLED ✓
CHE 118C (Orgo III — completes orgo lecture series) ★ PharmD prereq · Proj: B+ PHY 007A (General Physics) ★ PharmD prereq · Proj: A- ECN 001A (Principles of Microeconomics) ★ UCSF behavioral sci / Economics · Proj: A ASA 002 (Contemporary Issues of Asian Americans) · Proj: A ⚠ PSC 001 (Psychology) moved to Fall 2026 — UCSF behavioral sci / UCSD human behavior Lock in Franz Research Group Apply to hospital volunteer programs (Washington Hosp Fremont, El Camino MV) — apply by Apr 2026 Start → 8–10 hrs/week pharmacy 8–10 hrs/week Franz lab

Confirmed enrollment: 4 courses, 16 units — CHE 118C, PHY 007A, ECN 001A, ASA 002.

Winter 2026 final schedule confirmed: CHE 118B, BIS 002C, ENL 003, CLA 035, MGT 012Y (19 units).

ECN 001A (Microeconomics) confirmed enrolled Spring 2026 — satisfies UCSF's Economics requirement within the 19-unit behavioral science block.

PSC 001 (Psychology) moved to Fall 2026 where it pairs naturally with SOC 001.

CHE 118C completes the Organic Chemistry lecture series.

PHY 007A includes an integrated Discussion/Laboratory component (5 hrs/wk per UC Davis catalog) — no separate lab section needed; UOP physics + lab requirement satisfied by PHY 007A alone.

Grade projections: CHE 118C → B+ (upside A-) · PHY 007A → A- (downside B+) · ECN 001A → A · ASA 002 → A.

Sum 2026
Between Y2–Y3

No Classes — Full Execution Sprint

HOURS + LAB + VOLUNTEER
20–25 hrs/week pharmacy tech ★ priority · target 60–80 hrs total by end of summer 10–12 hrs/week Franz lab 6–8 hrs/week clinical hospital volunteering ★ new Priority-register EXB 106/106L for Winter 2027 the moment enrollment opens (Sep/Oct) Confirm Fall 2026 enrollment (NPB 101, BIS 102, PHY 007B, SOC 001, UWP) Ask Franz lab PI about LOR — confirm willingness by end of summer Ask pharmacist supervisor to be LOR writer — give full summer runway PHY 007A lab confirmed integrated — no separate PHY 007AL needed ✓ Run PharmCAS GPA estimator with Spring 2026 grades + actual transfer grades Take journal notes after every volunteer shift — raw material for personal statement

No coursework — highest-leverage non-academic window in the entire plan.

Clinical Volunteering Strategy: Apply to hospital volunteer programs in March–April 2026 (4–8 week onboarding pipeline). Top targets from Fremont: Washington Hospital Healthcare System (2000 Mowry Ave — closest, pharmacy dept access, ask for oncology or pharmacy placement) and UCSF Benioff Children's Hospital Oakland (510-428-3000 — UCSF affiliation strongest for UCSF PharmD narrative). South/West Bay options: El Camino Health Mountain View (650-940-7000 — nationally recognized clinical pharmacy program, 25 min via Dumbarton Bridge), Stanford Medical Center Palo Alto (650-723-4000 — highest prestige, 30 min), Santa Clara Valley Medical Center (408-885-5000 — county safety net hospital, strongest for UCSF health equity narrative).

Target 50–80 hours across the summer at one consistent setting — consistency beats volume. When applying, state explicitly that you are a licensed pharmacy technician pursuing a PharmD and request pharmacy, oncology, or clinical floor placement.

After each shift, write a brief journal note about one specific pharmacist interaction — these notes become the raw material for your personal statement.

Note on volunteer vs. tech hours: Your pharmacy tech license is more impressive than volunteering. Do not reduce tech hours to add volunteer hours — run both in parallel. 20–25 hrs pharmacy + 6–8 hrs volunteer + 10–12 hrs lab is a full but manageable summer schedule with no courses.

Fal 2026
Year 3 · Q1

PharmD Science Core — Manageable Load

STEADY
NPB 101 (Systemic Physiology, 5 units) ★ PharmD prereq · Proj: A- BIS 102 (Structure & Function of Biomolecules, 3 units) ★⁴ · Proj: B+ PHY 007B (General Physics II, 4 units) — NPB degree req · Proj: B+ SOC 001 (Sociology — UCSF 19-unit req, 4 units) · Proj: A PSC 001 (Psychology) ★ UCSF behavioral sci / UCSD human behavior · Proj: A UWP 1 or UWP 104 (English Writing #2, 4 units)⁵ · Proj: A 10–12 hrs/week pharmacy (~100 hrs total) 10–12 hrs/week Franz lab Register for Win'27 EXB 106/106L — priority enrollment opens Oct/Nov, fills immediately

5–6 courses — heaviest quarter in the plan; PSC 001 adds one light course alongside the science core.

PSC 001 moved from Spring 2026 to here — pairs naturally with SOC 001. ECN 001A confirmed Spr'26 + PSC 001 + SOC 001 here = Economics + Psychology + Social Science all covered for UCSF's 19-unit behavioral science block.

NPB 101 is 5 BCPM units — your single best GPA opportunity this quarter; push hard for A-.

BIS 102 must land here as gatekeeper before BIS 103 in Winter.⁴

PHY 007B is an NPB degree requirement (not a pharmacy prereq) — deferred from earlier plan to make room for BIS 102.

All CHE elective courses (130A, 131, 130B, 107A, 107B, 124A, 135, 150) removed from all pre-application quarters — none are pharmacy prereqs or NPB requirements, all deferred to Fall 2027 or later.

Register for EXB 106/106L the moment priority enrollment opens — this course fills within hours.

Win 2027
Year 3 · Q2

Anatomy + Biochem II — Most Critical Quarter

HARDEST QUARTER
EXB 106 (Human Gross Anatomy, 4 units) ★ PharmD prereq⁶ · Proj: A- EXB 106L (Anatomy Lab, 3 units) ★ PharmD prereq⁶ · Proj: A-/A BIS 103 (Bioenergetics & Metabolism, 3 units) ★ PharmD prereq · Proj: B+ NPB 110C (Foundations 3: Physiology, 2 units — reduced due to NPB 101 overlap) · Proj: A UWP 104F (Writing in Health Professions, 4 units — optional) · Proj: A 8–10 hrs/week pharmacy (~150 hrs total) 10–12 hrs/week Franz lab

This quarter is the single most important quarter in the pre-application plan.

EXB 106 + 106L combined are 7 BCPM units — the largest science GPA opportunity remaining before application.

BIS 103 properly follows BIS 102 from Fall 2026.

NPB 110C is only 2 units for you (reduced credit due to NPB 101 overlap — confirm with BASC advisor).

CHE 135 removed — not a pharmacy prerequisite or NPB requirement; deferred to Fall 2027 if still desired.

Total load: 12–16 units depending on UWP 104F.

If EXB 106 enrollment fails: use Ohlone BIOL 231 or Foothill BIOL 40A as CC backup⁶ — get written UCSF/UCSD equivalency confirmation in advance.

Confirm with BASC whether NPB 101 substitution for NPB 110C reduces it to 2 units or if you must enroll in the full 5-unit section.

Spr 2027
Year 3 · Q3

All PharmD Prerequisites Complete

MILESTONE ★
MMG 102 (Microbiology, 3 units) ★ PharmD prereq · Proj: A · must be Spr'27 — not Fall'27 CMN 001 (Public Speaking, 4 units) ★ PharmD prereq⁷ · Proj: A NPB 101L (Systemic Physiology Lab, 3 units) — NPB lab req · Proj: A-/A GE Humanities (4 units — toward UCSF 28-unit block) · Proj: A 180–200 hrs pharmacy total ★ 10–12 hrs/week Franz lab Draft personal statement — oncology pharmacy + Franz lab research narrative Formally request LORs from Franz PI, pharmacist supervisor, and science faculty

All PharmD prerequisites complete at end of this quarter.

MMG 102 must land here — PharmCAS opens July 10 and Fall 2027 Microbiology will not appear on your transcript. MMG 102 satisfies USC's Microbiology requirement and provides redundancy for UCSD's Anatomy/Micro/Biochem slot.

CMN 001 closes the public speaking gap required by UCSF and UCSD.

NPB 101L satisfies the NPB lab degree requirement and pairs well here — physiology fresh from Fall 2026 NPB 101.

UWP written elsewhere if not yet completed.

Confirm with BASC whether MMG 102 can double-count as both a pharmacy prereq and an NPB Additional Depth Elective — this would save a slot in Year 4.

Begin formal LOR conversations now with the full summer as runway for writers.

Sum 2027
Pre-Application

No Classes — Application Submission Window

🎯 SUBMIT
Submit PharmCAS July–Aug after Winter 2027 grades post ★ critical timing Finalize and proofread personal statement — all school-specific supplements Confirm all 3 LOR writers have submitted via PharmCAS Complete PharmCAS transcript entry — verify BCPM classification of every course Pay and submit to all 9 schools simultaneously Continue pharmacy tech hours — push toward 180+ total Notify Franz lab PI application is submitted — maintain lab relationship Begin light interview prep — MMI practice, research 90-sec narrative Confirm Fall 2027 enrollment (NPB 110B, BIS 101, NPB 101L) 10–15 hrs/week pharmacy (maintain, don't peak) Franz lab scaled to 6–8 hrs/week

No coursework — this summer is entirely owned by the application.

The ideal submission window is July–August 2027, after Winter 2027 grades have posted. Submitting before Winter grades appear removes the most important transcript data point — the hardest quarter of the plan — from your initial file. Wait for grades, verify they match projections, then submit. Do not submit in June.

Personal statement theme: oncology pharmacy + Franz lab research perspective. Do not mention deferral strategy in application.

Apply to all 9 schools: UCSF, UCSD, USC, UCI (CA targets) · UW, OSU (out-of-state matches) · UOP, WesternU, UA (safeties).

Out-of-state applicants must plan for CPJE self-study after graduation — not a barrier, just an extra step that requires awareness.

Fal 2027
Year 4 · Q1

Interview Season + NPB Major Progress

INTERVIEWS
NPB 110A (Foundations 1: Cell & Molecular Bio, 5 units) PHY 007C (General Physics III, 3 units — NPB degree req) NPB depth elective (NPB 168 or NPB 113, 3–4 units) CHE 130A (optional — first CHE elective post-application) 8–10 hrs/week Franz lab Interview prep Oct–Dec · respond to invitations CHE 124A, CHE 135, CHE 131 available here if bandwidth exists

Application submitted — focus on interviews and NPB degree completion.

NPB 110A starts the Foundations sequence (110A → 110B → 110C) — must come before 110B.

PHY 007C completes the NPB physics degree requirement (007A done Spr'26, 007B done Fal'26, 007C completes the series here).

Keep workload light to allow full interview travel and prep bandwidth.

CHE electives (130A, 131, 130B, 107A, 107B, 124A, 135, 150) are now available for the first time — take whichever interests you most if schedule and GPA allow, but treat them as optional enrichment, not obligations. These were correctly deferred from pre-application quarters.

Win–Spr '28
Year 4 · Q2–3

Decision Point — Finish the Degree

🎓 DECISION
PharmD interviews Dec'27–Mar'28 NPB 110B (Foundations 2: Neurobiology, 5 units) NPB 110C (Foundations 3: Physiology — full 5 units if not yet taken) BIS 101 (Genes & Gene Expression, 4 units — NPB depth req) NPB depth electives (2 additional to complete 4-elective requirement) CHE 130B, CHE 135, CHE 124A (optional electives) Franz lab continues 6–8 hrs/week Finish degree — graduate Spring 2028

By March 2028: evaluate PharmD offers. If admitted to UCSF/UCSD → accept Fall 2028.

NPB 110B must follow 110A (Fall 2027).

BIS 101 (Genes & Gene Expression) is an NPB depth requirement — no pharmacy school requires genetics as a standalone prereq so it belongs post-application.

Complete any remaining NPB depth electives for the 4-elective requirement.

Confirm with BASC that the full degree audit is satisfied before submitting graduation application.

Deferral only considered after admission in hand — frame as professional development, not exploration.

Master Checklist

Pharmacy Experience

Update resume (NPB major, Orgo done, PharmD goal)
This week
Start CA Pharmacy Technician license application (PTCB route)
This week
Apply to 8–10 positions (Kaiser Fremont, UC Davis Health, hospital pharmacies first)
Mar 2026
Secure pharmacy position, begin 8–12 hrs/week
Apr 2026
100 hrs pharmacy documented
End Fal'26
150 hrs pharmacy documented
End Win'27
180–200 hrs pharmacy documented — prioritize hospital/clinical settings over retail; supervised hospital hours carry stronger narrative weight than passive retail beyond the 150-hr mark
End Spr'27

Clinical Hospital Volunteering

Confirm immunization records complete at Student Health (MMR, varicella, Hep B series, TB test, flu shot) — required before any hospital will clear you
Mar 2026
Submit volunteer applications to Washington Hospital Fremont (510-797-1111 · washingtonhealth.com) AND El Camino Health Mountain View (650-940-7000 · elcaminohealth.org) simultaneously — apply to both, take whichever opens first
Mar–Apr 2026
Apply also to UCSF Benioff Children's Oakland (510-428-3000) — UCSF affiliation strongest for UCSF PharmD application narrative; or Stanford Medical Center Palo Alto (650-723-4000) for prestige option
Mar–Apr 2026
In volunteer application: state explicitly you are a licensed pharmacy technician pursuing PharmD · request pharmacy dept, oncology, or clinical floor placement · call to follow up (do not just submit online)
Apr 2026
Complete hospital orientation and background check — allow 4–8 weeks from application to first shift
May 2026
Begin consistent shifts 6–8 hrs/week from June through August — consistency beats sporadic volume
Jun 2026
Journal one specific pharmacist interaction or clinical observation after every shift — these notes become your personal statement and interview material
Jun–Aug 2026
50–80 clinical volunteer hours documented by end of summer 2026
End Sum'26

Anatomy Strategy

Contact UC Davis registrar — confirm EXB 106 enrollment restrictions
By Spr'26
Identify 2 community college backup options (Ohlone BIOL 231, Foothill BIOL 40A)
By Spr'26
Email UCSF + UCSD admissions — confirm CC anatomy equivalency in writing
By Spr'26
Pre-register for CC backup anatomy course (even if planning EXB 106)
By Fal'26
Register for EXB 106/106L during priority enrollment (Oct–Nov 2026)
Oct–Nov'26
Complete EXB 106/106L (Anatomy)
Win'27

Coursework & Prerequisites

Schedule NPB advisor meeting (confirm NPB + Electives track)
This week
Schedule HPA (Health Professions Advising) appointment
This week
Verify all prerequisites on UC Davis HPA Pharmacy Prerequisites Chart
Mar'26
Complete CHE 135 (Medicinal Chemistry) — highest value elective
Fal'26
Complete MMG 102 (Microbiology)
Spr'27
All prerequisites complete ★
End Spr'27
CHE 124A (Inorganic I) — only if GPA ≥3.6
Fal'27

Application & Research

Email Prof. Franz — confirm start date, hours, project assignment
This week
Confirm which Franz lab project has publication potential
End Spr'26
Present at UC Davis Undergraduate Research Conference
Apr'27
Begin drafting PharmD personal statement
Spr'27
Request letters of recommendation (pharmacist + science faculty)
Spr'27
Submit PharmCAS application ★
Aug 1 '27
Interview prep + attendance (UCSF, UCSD, UCI, USC)
Oct–Mar'28
Clinical Volunteering Strategy — Why, Where, and How Much
The Honest Framing First
You already have a significant advantage that most PharmD applicants don't: you are a licensed pharmacy technician with active hours. This is not the same as shadowing or volunteering — it is paid, licensed, patient-facing professional experience. Admissions committees distinguish clearly between these categories. A student with 200 hours of pharmacy tech work is in a materially stronger position than a student with 200 hours of pharmacy volunteering, because the tech role carries legal responsibility, requires demonstrated competency, and reflects a real professional commitment to the field rather than exploratory observation.

So the question isn't "would clinical volunteer hours help" in isolation — it's "what does adding clinical volunteer hours do to your application relative to what you already have, and is that the best use of your summer time."
Where Clinical Volunteer Hours Actually Add Value For Your Specific Profile
Your current profile has three strong pillars: pharmacy tech experience, Franz lab medicinal chemistry research, and a competitive GPA trajectory. What it doesn't have yet — and what clinical volunteering directly addresses — is breadth of patient care exposure beyond the pharmacy setting.

UCSF and UCSD in particular evaluate applicants holistically and look for evidence that you understand healthcare beyond the dispensing and compounding side of pharmacy. Admissions essays and interviews at these programs frequently probe whether applicants have witnessed pharmacists operating in clinical team environments — hospital rounds, medication reconciliation, patient counseling in inpatient or ambulatory care settings. If all your pharmacy hours are retail or community pharmacy, that's a meaningful gap in your ability to speak to clinical pharmacy practice during interviews.

Clinical volunteering — specifically hospital volunteering — fills exactly that gap. Not because the hours themselves are impressive, but because they give you firsthand exposure to the clinical environment that pharmacists increasingly work in, and they give you something distinct to discuss in your personal statement and interviews.
What Type of Clinical Volunteering Matters — and What Doesn't
High Value ★
Anything that puts you in proximity to healthcare teams in an inpatient or outpatient clinical setting. Hospital volunteering (UC Davis Medical Center, Sutter Davis). Patient transport, med-surg floor, ED volunteering, oncology units. Ambulatory care clinics. Any role where you observe interdisciplinary care or patient interaction with clinical staff.
Moderate Value
Free clinic volunteering, community health fairs, health education programs. These demonstrate community engagement and health equity awareness — UCSF values this specifically. Less directly relevant to clinical pharmacy practice than hospital volunteering, but additive if you can speak to them substantively.
Lower Value For Your Profile
General community service unrelated to healthcare. Administrative hospital volunteering with no patient contact. Anything sporadic — a few shifts you can't speak to in depth. These add resume filler without adding narrative substance. Admissions committees can tell the difference.
The Realistic Time Math for Summer 2026
Summer 2026 is your highest-leverage non-academic window. Here is what is already competing for that time:
Pharmacy Tech — 20–25 hrs/wk
Priority. Building toward 150–200 total hours at application. Do not sacrifice these hours for anything else.
Franz Lab — 10–12 hrs/wk
Non-negotiable for maintaining research continuity and the PI relationship needed for your letter of recommendation.
Clinical Volunteering — 6–8 hrs/wk
Target 50–80 total hours across the summer at one consistent setting. Enough to speak to substantively in an essay and interview.
Application Groundwork
EXB 106 priority registration (Sep/Oct). PharmCAS GPA estimator. LOR conversations. Fall 2026 enrollment confirmation.
At 20–25 pharmacy tech hours + 10–12 lab hours + 6–8 volunteer hours, you're looking at 36–45 hours of committed weekly time. That's a full schedule but manageable for a summer with no classes.
The Interview Angle — Where It Pays Off Most Concretely
The most concrete benefit of clinical volunteering isn't on the written application — it's in the MMI and traditional interview format used by UCSF, UCSD, USC, and UCI. A very common prompt is some version of: "Tell me about a time you observed a pharmacist in a clinical setting and what you learned from it" or "Why clinical pharmacy specifically rather than community pharmacy?"

If your only answer draws from a retail tech setting, you're answering from a narrower base than an applicant who can speak to both environments. Adding even one summer of hospital volunteering gives you a second, distinct experience to draw from in those answers — and it makes your narrative arc more coherent: you started as a retail tech, sought out hospital exposure to understand clinical practice, and are now pursuing PharmD to move from technician to clinical pharmacist.
The Two Scenarios
When volunteering is genuinely additive
Your pharmacy tech hours have been primarily retail or community pharmacy. Clinical hospital volunteering adds a new dimension — exposure to pharmacists in clinical team environments — that creates a coherent, compelling narrative arc UCSF and UCSD respond to.
When the trade isn't worth it
If adding volunteer hours means reducing pharmacy tech hours or lab hours. A student with 180 tech hours and 0 volunteer hours is a stronger applicant than one with 120 tech hours and 60 volunteer hours. The licensed tech role is simply more credentialed. Never sacrifice tech or lab time for volunteering.
Bottom Line Recommendation
Yes — add clinical volunteering in Summer 2026, but be strategic about it. Target UC Davis Medical Center or Sutter Davis specifically — both accessible from Davis, both give genuine clinical exposure. Apply in March–April 2026 (4–8 week onboarding pipeline). Commit to a consistent schedule: 6–8 hrs/week for 8–10 weeks → 50–80 total hours.

Prioritize settings where you will observe pharmacists or pharmacy staff in clinical team environments — med-surg floors, oncology units, and ambulatory care clinics are most relevant. ED volunteering is high-intensity and impressive but patient contact is often more limited than it appears.

Keep pharmacy tech as the primary professional experience. Frame volunteering in your personal statement as deliberate exposure-seeking — you wanted to understand the full spectrum of pharmacy practice from dispensing to clinical decision-making, and you pursued that understanding proactively. That framing turns a summer activity into a narrative about intentional professional development, which is exactly what UCSF and UCSD want to see.

After each shift, write one brief journal note about a specific pharmacist interaction or clinical moment observed. These notes become the raw material for your personal statement and interview answers. Don't skip this step.
Warning Risk Ranking — Probability of Causing Application Failure
The warnings below are ranked by their realistic probability of blocking or materially damaging a PharmD application if not acted on. Risk reflects both likelihood of occurring AND severity of consequence.
🔴 Critical — Application-Blocking if Ignored
#1
² CHE 118 Orgo Lab — Equivalency Not Confirmed in Writing
If UCSF or UCSD reject CHE 118A/B/C as satisfying their orgo lab requirement, you are ineligible to apply — orgo + lab is a hard prerequisite at both schools. This is the only warning where the default assumption could be silently wrong on a transcript that shows no standalone lab course number. The fix (getting written confirmation from admissions) is trivially easy. The consequence of not doing it is disqualification. Act on this before any other warning.
Prob: High
if unverified
#2
⁴ BIS 102 Prerequisite Chain — If This Course Slips, BIS 103 Slips With It
BIS 103 (Cell/Mol Bio — UCSD required) cannot be taken without BIS 102 complete. If BIS 102 gets dropped from Fall 2026 for any reason — enrollment conflict, GPA fear, overload — the entire BIS chain shifts by one quarter. BIS 103 then moves to Spring 2027 at the earliest, and the application timeline compresses dangerously. There is no slack in this sequence. BIS 102 in Fall 2026 is non-negotiable if UCSD is a target school.
Prob: Medium
chain failure
#3
ˢ Spring 2026 Enrollment — Built on Unconfirmed Assumptions
Spring 2026 enrollment confirmed from screenshots: CHE 118C, ECN 001A, PHY 007A, ASA 002 — 16 units. PSC 001 moved to Fall 2026.
Prob: Low–Med
but cascading
🟡 Moderate — Creates Meaningful Friction or Gaps
#4
⁶ EXB 106/106L Anatomy — Enrollment Failure Without Pre-Secured Backup
EXB 106 is heavily enrolled and not guaranteed. If enrollment fails and no backup CC section is pre-secured, there is a one-quarter gap before anatomy can be retaken. Because this plan uses EXB 106 to satisfy UCSD's Anatomy slot, failure delays that requirement. However, because BIS 102 and MMG 102 also cover UCSD's Anatomy/Micro/Biochem slot, EXB 106 failure is not fatal — just suboptimal. Risk is moderate not critical precisely because of the built-in redundancy.
Prob: Low–Med
manageable
#5
UCSF 19-Unit Behavioral Science — Unit Count May Fall Short
ECN 1A + ECN 1B + PSC 1 + SOC 1 covers the required subject categories but the unit total needs explicit verification. If those courses only total 16 units (4+4+4+4 = 16 quarter units = ~10.6 semester units), there may be a shortfall against UCSF's 19-unit threshold depending on how they count. One additional behavioral science GE in any lighter quarter solves this completely. Low effort fix, but must be caught before application.
Prob: Medium
easy fix
#6
BIS 102 Lab Component — UCSD "With Lab" Interpretation
UCSD's Anatomy/Micro/Biochem slot says "with lab." BIS 102 at UC Davis has no standalone lab section — the course is lecture-only. If UCSD interprets this strictly, BIS 102 alone does not satisfy the slot, and EXB 106/106L or MMG 102 (both of which have integrated labs) become mandatory rather than optional. Again, the plan already includes both EXB 106L and MMG 102, so this risk is already hedged. But BIS 102 should not be counted as the primary backup for this slot.
Prob: Low–Med
hedged
🟢 Low — Housekeeping; Unlikely to Cause Real Damage
#7
⁵ English Writing #2 — Likely Already Satisfied or Trivially Fixed
If a prior UWP or ENL course already covers this, it's done. If not, UWP 1 is one of the easiest 4-unit courses on campus. No admissions committee rejects a competitive applicant over a writing course they haven't taken yet — they defer an offer pending completion. Zero catastrophic risk. Just confirm and slot it.
Prob: Low
easy confirm
#8
³ Physics at Community College — Verify ASSIST.org First
CC physics is widely accepted, well-articulated at UC Davis, and not a scrutinized course in pharmacy admissions. The only realistic failure mode is enrolling in a CC physics course that doesn't have UCSD equivalency — and this is solved in 10 minutes on ASSIST.org before registration. Probability of causing application failure: near zero if the basic verification step is done.
Prob: Very Low
5-min fix
#9
⁷ Public Speaking (CMN 1) — No Realistic Risk
A 4-unit public speaking course with no prerequisites, offered every quarter. It fits anywhere in the plan. Even if somehow overlooked, every PharmD program that requires it lists it as a completable-pending course. Ranked last because it simply cannot go wrong with any reasonable planning effort.
Prob: Negligible
any quarter
#10
¹ Spring 2026 Unit Load (Adding NPB 110A)
Adding a 5th course is presented as optional and clearly flagged. If it causes a GPA dip, that's a real cost — but the framing already makes it opt-in and easy to skip. The timeline explicitly absorbs NPB 110A into Fall 2026 if Spring is too heavy. No application-failure risk; purely a GPA management call.
Prob: Low
optional anyway
Bottom line: The only warning that can silently block you without obvious warning signs is #1 (CHE 118 orgo lab). Everything else either has a clear signal before it becomes a problem, is already hedged in the plan, or is trivially fixable. Act on #1 and #2 this quarter. #3 (verify Spring enrollment) should be done today.
Warnings & Verification Checklist
⛔
Note ¹ Spring 2026 Unit Load — Confirmed at 16 Units
Spring 2026 is confirmed at 4 courses, 16 units (CHE 118C, PHY 007A, ECN 001A, ASA 002). NPB 110A was not added and does not need to be — it is an NPB major requirement only, not a PharmD prerequisite, and is appropriately placed post-application in Fall 2027.
⚠️
Verify ² CHE 118A/B/C Orgo Lab — Confirm with UCSF & UCSD Admissions
The CHE 118 series integrates lab work into each lecture course — there is no separate CHE 129A/B required. However, UCSF and UCSD both list "Organic Chemistry lecture and laboratory" as separate line items. Since CHE 118 doesn't produce a standalone lab course number on the transcript, admissions may ask for clarification. Action: Email UCSF and UCSD admissions directly and ask them to confirm in writing that CHE 118A + 118B + 118C satisfies their orgo + lab requirement. Do this before submitting the PharmCAS application.
✅
Confirmed ³ Physics — PHY 007A Complete Spring 2026
PHY 007A (General Physics) confirmed enrolled Spring 2026 at UC Davis, satisfying the physics prerequisite for all 9 programs. No CC physics course needed. Confirmed via UC Davis course catalog: PHY 007A includes an integrated Discussion/Laboratory component (5 hrs/wk) — there is no separate PHY 007AL. The lab is built into the 4-unit course. UOP's physics + lab requirement is satisfied by PHY 007A alone.
⛔
Critical ⁴ BIS 102 Must Come Before or Concurrent with BIS 103
BIS 103 (Bioenergetics & Metabolism) has BIS 102 as a prerequisite. The current plan places BIS 102 in Fall 2026 and BIS 103 in Winter 2027 — this sequencing is correct. Do not attempt to take BIS 103 without BIS 102 already completed or concurrent. If BIS 102 gets dropped from Fall 2026 for any reason, BIS 103 must also shift — do not leave a gap. BIS 103 is a UCSD prerequisite (Cell and/or Molecular Biology requirement) so it must be completed before the Aug 2027 application.
⚠️
Verify ⁵ English Writing #2 — Confirm Whether Already Satisfied
ENL 003 (Intro to Literature, Winter 2026 — in progress) counts as English #1. Both UCSF and UCSD require 2 English composition courses with a writing component. Action: Check whether any prior coursework — AP English, transfer credit, or another ENL/UWP course — satisfies the second requirement. If not, UWP 1, UWP 101, or UWP 104 must be added — slotted in Fall 2026 (preferred) or Spring 2027 at the latest. These are easy, low-stress courses and should not affect GPA meaningfully.
⚠️
Verify ⁶ EXB 106/106L Anatomy — Written Equivalency from UCSF & UCSD
If EXB 106/106L enrollment at UC Davis fails, the backup plan is Ohlone BIOL 231 or Foothill BIOL 40A at community college. Before relying on a CC backup: get written confirmation from UCSF and UCSD admissions that the specific CC course is an accepted anatomy equivalent. Request this confirmation during Spring 2026 — do not wait until enrollment actually fails. Register for a CC backup section in advance even if planning to take EXB 106, so the spot is held.
ℹ️
Action ⁷ Public Speaking (CMN) — Required by Both UCSF & UCSD
UCSF requires CMN 3 or CMN 5 (Interpersonal Communication). UCSD requires "Public Speaking or Debate" (CMN 1 satisfies this). CMN 1 (Intro to Public Speaking) satisfies both programs simultaneously and is one of the lightest 4-unit courses on campus. Slot CMN 1 in Spring 2027. If Spring 2027 feels overloaded, CMN 1 can move to Fall 2026 as a relatively easy addition — it has no prerequisites and meets once or twice a week.
⚠️
Verify UCSF Behavioral Sciences — 19-Unit Requirement
UCSF requires a total of 19 units across Behavioral Sciences, which must include Economics, Psychology, and a Social Science (Sociology or Anthropology). Current confirmed status: ASA 002 (Spr'26) + ECN 001A (Spr'26, confirmed enrolled) cover Economics and contribute to the block. PSC 001 (Fal'26) covers Psychology. SOC 001 (Fal'26) covers Social Science. Still needed: verify total unit count across all behavioral science courses reaches 19. ASA 002 (4) + ECN 001A (4) + PSC 001 (4) + SOC 001 (4) = 16 quarter units — likely 1 unit short of UCSF's 19-unit threshold. One additional behavioral/social GE in a lighter quarter (e.g. MGT 012Y from Win'26 may count — confirm with UCSF) resolves this completely. Low effort fix but must be confirmed before application.
ℹ️
Note Human Behavior Requirement — PSC 1 Satisfies UCSD
UCSD requires 1 course in Human Behavior (psychology, sociology, cultural anthropology, or related). PSC 1 moved to Fall 2026 almost certainly satisfies this. Confirm on the UCSD Institution Course Equivalencies page at pharmacy.ucsd.edu to make sure PSC 1 is listed as an approved Human Behavior course for UC Davis students.
⚠️
Resolved ˢ Winter 2026 & Spring 2026 Enrollment — Both Confirmed
Winter 2026 final schedule confirmed: CHE 118B (4 units) · BIS 002C (5 units) · ENL 003 (4 units) · CLA 035 (3 units) · MGT 012Y (3 units) = 19 units total. Spring 2026 confirmed: CHE 118C · PHY 007A · ECN 001A · ASA 002 = 16 units. ECN 001A confirmed enrolled Spring 2026 — UCSF Economics requirement satisfied. PSC 001 moved to Fall 2026 where it pairs with SOC 001. PHY 007A lab confirmed integrated per UC Davis catalog (Discussion/Laboratory 5 hrs/wk) — no separate PHY 007AL needed. UOP physics + lab requirement resolved.
ℹ️
Note ᵍ PharmCAS GPA Methodology — Verified Transcript Data
GPA projections in v13 are based on verified transcript data from the actual UC Davis unofficial transcript and enrollment screenshots. Confirmed UC Davis GPA after Fall 2025: 3.655. Confirmed UC Davis BCPM: 37 units, 136.2 quality points, 3.681 science GPA. Key BCPM drag points: MAT 017B (B, 3.0) and CHE 118A (B+, 3.3). Transfer units: 31.5 units from Mission College and Ohlone — individual grades unknown and are the largest remaining GPA uncertainty. PharmCAS recalculates from scratch using all institutions; the scenario table above shows conservative (transfer avg 3.7) and optimistic (all A's) cases. Action: run the PharmCAS GPA estimator at help.liaisonedu.com with your actual transfer grades immediately — this resolves the biggest remaining unknown. Key methodology notes: (1) MAT 017 series fully confirmed complete — no MAT 021 needed. (2) AP credit excluded per PharmCAS. (3) P-grade courses excluded. (4) BCPM = Biology, Chemistry, Physics, Math only. (5) Winter 2026 BCPM courses: CHE 118B (4 units) + BIS 002C (5 units) = 9 BCPM units. ENL 003, CLA 035, MGT 012Y are NOT BCPM. PSC 001, ASA 002, SOC 001, CMN 001 are NOT BCPM.
⚠️
Verify BASC Advisor — Two Items Require In-Person Confirmation
Two NPB degree questions require a BASC (Biological Sciences Academic Success Center) advising appointment before the schedule can be finalized: (1) NPB 101 substitution for NPB 110C — the current plan assumes NPB 101 (Systemic Physiology) reduces NPB 110C from 5 units to 2 units by overlap credit. Confirm whether this is a formal substitution requiring BASC approval or whether 110C must still be taken at full 5 units. (2) MMG 102 double-count — confirm whether MMG 102 can satisfy both the pharmacy microbiology prerequisite AND count as the NPB Additional Depth Elective simultaneously. If yes, this frees one elective slot in Year 4. Schedule this appointment during Spring 2026.
ℹ️
Note Clinical Volunteering — Value and Approach
Clinical hospital volunteering is additive to, not a replacement for, pharmacy tech hours. Your tech license is more credentialed than volunteering — do not reduce tech hours to add volunteer hours. The value of volunteering is breadth of patient care exposure beyond the pharmacy counter: observing pharmacists in clinical team environments, witnessing medication reconciliation, attending rounds. This gives you a second distinct experience to draw from in UCSF/UCSD MMI interviews when asked about clinical pharmacy practice. Target hospitals from Fremont/Davis: Washington Hospital Fremont (closest, pharmacy dept access) · El Camino Health Mountain View (nationally recognized clinical pharmacy program) · Stanford Medical Center Palo Alto (prestige, 30 min via Dumbarton) · UCSF Benioff Children's Oakland (UCSF affiliation, strongest for UCSF application) · Santa Clara Valley Medical Center (county safety net — strongest for UCSF health equity narrative). Apply March–April 2026 for June start. 50–80 hours across summer 2026 is sufficient — consistency beats volume, and one well-known setting beats scattered hours at multiple hospitals.
If You Don't Get In — Options, Alternatives & CA School Tier Guide
A rejection from UCSF, UCSD, and USC is not the end of the path — it's a branch point. The options below range from "accept and go" to "pivot entirely," and the right choice depends on why you were rejected and what the actual goal is. Each option is real. None of them is a failure.
Part 1 — Immediate Options After Rejection
①
Accept UOP or WesternU and Go — Most Underrated Option
Recommended
UOP admit: 50–65% WesternU admit: 55–70% ≥1 of both: ~85%
Both programs are fully ACPE-accredited. A PharmD from WesternU or UOP produces the same license and opens the same clinical pharmacist job market as a UC degree for the majority of pharmacy career paths. Kaiser, VA Medical Centers, Sutter, Dignity Health, and most hospital systems hire from both without meaningful distinction. The most significant real limitations are narrower rotation networks for competitive PGY2 programs at top academic medical centers, and weaker alumni networks for industry/academic roles. For general hospital pharmacy, ambulatory care, and specialty practice — the outcome is essentially the same. Do not decline an acceptance from UOP or WesternU to reapply without a specific, fixable reason for the original rejection.
②
Gap Year + Reapply — Right Move If GPA Was the Bottleneck
UCSF reapply: 20–30% UCSD reapply: 30–40% Only worth it if GPA was root cause
If rejections were GPA-driven and the science GPA specifically was the weak point, a gap year completing NPB 110A/B/C, BIS 101, and depth electives with strong grades raises the PharmCAS BCPM meaningfully. Simultaneously pharmacy hours grow to 400–500+ range, which is genuinely differentiating at UCSF and UCSD. The personal statement can be rewritten around what changed. Reapplication only makes sense if you can identify the specific factor that caused rejection and show it has changed. If rejection was holistic rather than GPA-driven, more time does not automatically change the outcome at the same schools.
③
Post-Bacc to Fix Science GPA — Surgical Approach
Same as ② — depends on GPA gain +0.2 sci GPA → est. +10–15% odds at UCSD/USC
If the cumulative GPA is strong but BCPM specifically was the rejection reason, targeted upper-division biology or chemistry coursework while working full-time as a pharmacy technician is more efficient than a full gap year. This approach accumulates pharmacy hours, income, and GPA improvement simultaneously. Most effective when the science GPA gap is 0.2–0.4 points and identifiable courses (BIS 102, NPB 101, EXB 106) produced the drag. Adds roughly one year to timeline but with a specific, measurable improvement to show in the reapplication.
④
Expand Geographically — CA Has the Most Competitive Market in the US
OSU admit: 35–50% UW admit: 25–35% UA admit: 50–65% ≥1 of all 3: ~92%
California's pharmacy school demand far outstrips seat supply — it's one of the most competitive PharmD markets nationally. Oregon, Washington, Arizona, Nevada, and Colorado all have ACPE-accredited programs with less congested applicant pools. University of Oregon, University of Washington, University of Arizona, and Midwestern University (Glendale, AZ) all accept California residents and have admitted profiles where a 3.70/3.58 applicant is competitive. The PharmD degree is fully portable — California licensure via NAPLEX is available regardless of where the degree was earned. Tradeoff is relocating for four years.
⑤
PharmD/PhD or Research Track — Different Committee, Different Lens
UCSF PharmD/PhD: ~15–25% UCSD PharmD/PhD: ~20–30% Separate committee from standard PharmD — research potential weighted heavily
A rejection from the standard PharmD program at UCSF does not close the door on the PharmD/PhD program — these are evaluated by separate committees with different criteria. Joint degree admissions weigh research potential, publications, and faculty fit far more heavily than pharmacy hours and personal statement narrative. The Franz lab background becomes a primary qualification here rather than a differentiator. If research is genuinely a core interest, the PharmD/PhD path at UCSF or UCSD may actually be a better fit than a standard PharmD from a lower-tier school. Note: odds here are estimated specifically for this profile's Franz lab background — without research experience they would be significantly lower.
⑥
MS Pharmaceutical Sciences — Fastest Path to Industry + Optional PharmD Later
USC MS PharmSci: ~55–70% Northeastern: ~60–75% Rutgers: ~65–75% Min GPA 3.0 most programs — 3.70 is competitive
A 1–2 year MS in Pharmaceutical Sciences (USC, Northeastern, Rutgers) gets you into pharma industry roles at $80–110k starting without requiring a PharmD. The reverse strategy — MS first, 2–3 years in industry, then optionally apply to PharmD with a stronger application and real industry experience — is a legitimate path that also resets the GPA narrative. Many people find they prefer industry and never return to PharmD, which is not failure but information. Franz lab NMR/HPLC experience is exactly what pharma formulation and analytical roles want.
⑦
Regulatory Affairs MS — High Floor, No Residency, Disease-Agnostic
USC MS Reg Sci: ~65–80% Northeastern: ~65–75% Johns Hopkins (online): ~60–70% USC requires min 3.0 GPA — accessible for this profile
USC MS in Regulatory Science, Northeastern, or Johns Hopkins programs lead to FDA drug approval roles, regulatory strategy at pharma, and pharmacovigilance. Career range $80–180k with no licensure exam required and no residency. Franz lab drug development context is cited as ideal preparation. This is described in the pathways framework as the most theme-neutral high-floor path — it works across small molecules, biologics, cell/gene therapies, and medical devices without specializing. A strong alternative if the goal is pharmaceutical industry engagement rather than direct patient care.
⑧
MS Clinical Research — Bridges Franz Lab to Clinical Development Pipeline
UCSF MS Clin Research: ~30–45% Stanford MS Epi: ~20–30% USC MS Reg Sci (clinical track): ~65–80% Franz lab + NPB = strong fit signal
UCSF MS in Clinical Research, USC MS in Regulatory Science, or Stanford MS in Epidemiology & Clinical Research. Applies across any disease area. Bridges bench research experience with the clinical trial design and regulatory pathway. Entry roles $65–85k as clinical research coordinator, $80–110k as trial manager mid-career. Lower income ceiling than PharmD but lower debt, no licensing exam, no residency, and the path is open now rather than requiring a 4-year program. Particularly strong fit given the Franz lab background and NPB major.
⑨
Pharmacology PhD — Fully Funded, No Debt, Research-Track Career
UCSF PSPG PhD: ~10–18% UCSD Pharmacology: ~15–25% UC Davis Pharmacology: ~25–40% Franz lab = competitive edge; fully funded = no debt
PhD programs in pharmacology at UCSF, Stanford, UCSD, or UC Davis are fully funded — no tuition, stipend provided (~$30–38k/year). No debt. Career range $120–180k in pharma industry or $90–150k in academia. A 3.70 GPA with genuine Franz lab research experience is a competitive application at UC programs. This path requires research to become the primary identity rather than clinical practice, but it leads to many of the same downstream outcomes — MSL roles, medical affairs, regulatory affairs, drug development — without the $180–220k debt load that comes with the PharmD. Best fit if research interest is genuine and not just application narrative. Note: PhD odds are highly faculty-dependent — identify 2–3 specific faculty whose research aligns with Franz lab work before applying, as this substantially improves outcomes.
Part 2 — What You Actually Miss at UOP or WesternU vs. UC Programs
✓ What You Don't Lose
Full ACPE accreditation — identical licensure eligibility nationally
Same NAPLEX + MPJE path — same license, same prescriptive authority
Access to the ASHP residency match system
Entry-level clinical pharmacist job market at Kaiser, VA, Sutter, Dignity Health, community hospitals
Same starting salary in equivalent roles ($125–155k)
Eligibility for hospital staff pharmacist, ambulatory care, specialty pharmacy roles
Ability to earn California licensure regardless of where PharmD was earned
✗ What You May Actually Lose
Rotation networks at top academic medical centers (UCSF, Stanford, UCLA)
Implicit preceptor familiarity advantage for competitive PGY2 residency programs
Industry and academic alumni network depth for pharma/research-track careers
Research opportunities during PharmD for anyone considering PharmD/PhD
Residency match rate advantage — WesternU: strong; KGI: #3 in CA; UOP: established
For oncology PGY2 at UCSF/Stanford specifically — real structural disadvantage
Brand signal in medical affairs / pharma hiring at major companies (Genentech, Roche)
Part 3 — Are UOP, WesternU, and KGI Legitimate? Honest Assessment.
All three are fully ACPE-accredited. ACPE accreditation is not tiered — a program either has it or doesn't. The short answer is yes for UOP and WesternU, yes with a caveat for KGI.
UOP (Pacific)
Oldest private pharmacy school in the western US — founded 1955. Highly established rotation network. WesternU NAPLEX pass rate ~92%, well above national average. Strong safety school for this profile. Average admitted GPA ~3.4. Tuition ~$45,900/yr. Legitimate and well-regarded within the profession.
WesternU (Pomona)
NAPLEX pass rate ~92% — significantly above national average of 74%. Strong clinical training emphasis. Active research faculty. Joint PharmD/MS option available. Tuition ~$47,000/yr. Cited as strong value relative to more expensive CA programs. One of the better private programs in California by outcome metrics.
KGI ⚠ Caveat
Legitimate and ACPE-accredited. Strong residency match: #1 private CA school, #3 overall in state for ASHP Phase I 2024 — 44% of Class of 2024 matched PGY1. However: NAPLEX first-time pass rate 62.8% (2024) vs. 74% national average. 1 in 3 graduates failing on first attempt is a documented, significant weakness. Strong if residency is the goal; concerning for direct licensure path. Tuition ~$47,369/yr. Industry fellowship program with biopharmaceutical companies is a real differentiator.
Part 4 — Full California PharmD Program Tier Guide
California has 14 accredited PharmD programs — more than any other state. Ranked by outcome quality (NAPLEX pass rate + residency match rate) not prestige or tuition.
School Tier NAPLEX Rate Avg GPA Tuition/yr Key Note
UCSF Elite ~100% ≥3.6 ~$38k (3yr) 3-year program. Top-ranked nationally. ~25% admit rate. Rotation network unmatched in CA.
UCSD Elite ~95%+ ~3.5 ~$39k Strong research emphasis. ~50% of graduates pursue post-grad degrees. ~100 seats.
USC Strong ~93%+ ~3.5 ~$60k Strong industry ties. Best private CA school for pharma industry pathway. Higher tuition.
UCI Strong Building ~3.4–3.6 ~$38k Newest UC pharmacy program (2020). Still building class profile and rotation network. Good value.
WesternU Mid ~92% ~3.3–3.5 ~$47k Best NAPLEX rate among private CA schools. Strong clinical training. Joint PharmD/MS. Pomona, CA.
UOP (Pacific) Mid ~88% ~3.4 ~$46k Oldest private pharmacy school in western US (1955). Established network. Stockton, CA. Auto-scholarship consideration.
KGI Mid 62–71% ⚠ ~3.2–3.4 ~$47k #1 private CA / #3 overall ASHP residency match 2024 (44%). NAPLEX rate well below national avg. Claremont Colleges. Industry fellowship program strong. Organ-system integrated curriculum.
Touro CA Mid ~80% ~3.2–3.4 ~$47k Unique 2+2 format. Joint PharmD/MPH available. Community health focus. Vallejo, CA — closest private option to UC Davis. ~50% admit rate.
Cal Northstate (CNUCOP) Mid Variable ~3.0–3.3 ~$47k Geographically closest to UC Davis — Sacramento. Newer program building rotation network. Joint PharmD/MD option unusual offering. CNUCOP serves Sacramento region.
Marshall B. Ketchum Mid ~80% ~3.0–3.3 ~$50k Health professions-only institution. Fullerton, CA. 5 APhA certifications integrated into curriculum. Solid community/clinical practice focus.
West Coast University Mid ~78% ~3.0–3.3 ~$46k Hybrid format (online + in-person). 33-month accelerated option. LA campus. CPJE pass rate strong. Hybrid format viewed differently by some residency programs.
Loma Linda Conditional ~85% ≥2.75 ~$46k Seventh-Day Adventist mission. Most lenient science prereqs in CA. Physiology not required. "Whole person care" focus including faith/ethics. Only apply if mission-aligned.
CHSU Newer Building ~3.0 ~$46k Clovis, CA (Central Valley). First university of its kind in Central Valley. Also has DO program. Newer — less established track record. Serves underserved healthcare market.
Chapman Avoid Variable No min. ~$78k ⚠ Most expensive pharmacy school in CA at $78,510/yr. No minimum GPA. Preferred GPA ≥3.0. Worst cost-to-outcome ratio in the state. Accredited and produces licensed pharmacists, but financially very hard to justify vs. alternatives.
RECOMMENDED OUT-OF-STATE — OR · WA · AZ
OSU — Oregon Match ★ 96.2% 🏆 ~3.2 sci ~$38k OOS* #5 nationally NAPLEX 2024. *$19k/yr auto tuition scholarship for non-residents ≥3.0 GPA — brings cost near in-state. PharmD/PhD + PharmD/MBA available. Best value in entire list. Proactively request CA APPEs Year 4 for CA return.
UW — Washington Match ~93% match† ~3.4–3.5 ~$52k OOS †Residency match rate (not NAPLEX). 93% Class of 2025. Rotates at UW Med Center + Seattle Cancer Care Alliance. Best CA-return trajectory of any OOS school. No auto scholarship. More expensive but strongest outcomes outside CA. PharmD/PhD + PharmD/MS options.
U Arizona — AZ Safety ≥95% 2.75+ pref. ~$36k OOS NIH funding rank #3 nationally (AACP). NAPLEX consistently above national avg. 100–140 seats, ~62% interview-to-admit. Rolling admissions — priority deadline Oct 1. 3.70 GPA is well above their median. Most accessible OOS safety. Growing Phoenix biotech/pharma corridor.
Part 4b — 4-Year Total Cost & Debt Reality
Tuition figures are annual rates. Total cost of attendance adds ~$20–25k/yr for living expenses in most markets. Debt at graduation assumes no scholarships beyond what's noted and standard graduate loan rates. Debt load materially affects residency flexibility — a $200k+ debt burden creates financial pressure to take the highest-paying first job rather than pursuing a competitive but lower-stipend PGY2 residency (~$55–65k/yr). This is a real tradeoff that should factor into school choice.
School Annual Tuition Program Length Tuition Total Est. Debt at Grad* Notes
UCSF ~$39k 3 years ~$117k ~$150–170k Public UC tuition. 3-year program saves 1 year of living costs vs 4-year programs. Best debt outcome among elite options.
UCSD ~$40k 4 years ~$160k ~$200–230k Public UC tuition. San Diego cost of living is high — living expense component increases total CoA.
UCI ~$39k 4 years ~$156k ~$195–225k Public UC tuition. Irvine CoL moderate vs UCSF/UCSD. Newer program — scholarship availability still developing.
USC ~$62k 4 years ~$248k ~$290–330k Private tuition at premium. Highest debt load of the match-tier schools. Strong industry ties somewhat offset by cost — but debt burden is significant. Scholarship available; competitive.
OSU ~$38k OOS* 4 years ~$152k* ~$185–210k* *After $19k/yr auto scholarship — full OOS tuition ~$57k. Scholarship brings effective rate near in-state (~$38k). Corvallis CoL is low. Best overall cost-outcome ratio in the list for non-residents.
UW ~$52k OOS 4 years ~$208k ~$255–290k Full OOS tuition; no auto scholarship. Seattle CoL is high. Outcomes justify cost for residency-track career — but debt load approaches USC levels. Worth it if competitive residency is the goal.
U Arizona ~$36k OOS 4 years ~$144k ~$175–200k Tucson CoL is low — significantly reduces living expense component vs CA schools. Strong cost-to-outcome ratio for OOS applicants. Comparable total debt to public CA programs.
UOP ~$46k 4 years ~$184k ~$220–250k Private. Stockton campus — CoL moderate. Established program, solid outcomes. Debt meaningful but not extreme for private school.
WesternU ~$47k 4 years ~$188k ~$225–255k Private. Pomona CoL moderate. Best NAPLEX of CA private schools (92%) partially justifies premium over UOP. Verify prereqs annually.
Chapman ⚠ ~$78k 4 years ~$312k ~$360–400k Most expensive pharmacy school in CA. At $370k+ total debt, monthly loan payments (~$3,500–4,000/mo) consume a large fraction of a pharmacist salary. Very hard to justify financially vs any alternative on this list.
Debt and residency flexibility: A PGY1 residency pays ~$55–65k/year. On a $300k debt load, standard 10-year repayment runs ~$3,200/month — consuming roughly 65–70% of take-home pay at residency salary. This creates real pressure to skip residency and take a direct staff pharmacist role at $130–155k. If competitive residency is a core goal, the school's debt load matters — not just its tier. UCSF's 3-year + public tuition structure produces the best debt-to-outcome ratio of any elite program. OSU produces the best debt-to-outcome ratio in the entire list for a non-resident. USC and UW produce strong outcomes but at debt levels that constrain post-graduation flexibility.
Part 5 — Will UOP/WesternU Graduates Have Harder Time Getting Hospital Clinical Roles?
General Hospital Roles — No Meaningful Difference
For staff pharmacist, clinical pharmacist, and most clinical specialist positions, employers hire from UOP and WesternU without distinction. Kaiser, VA Medical Centers, Dignity Health, Sutter, and most community hospital systems evaluate candidates on licensure, NAPLEX score, and interview performance — not which accredited PharmD program they attended. The job posting does not ask where the PharmD was earned.
Competitive PGY2 Residencies — Real Structural Disadvantage
For highly competitive PGY2 programs at UCSF, Stanford, UCLA, and UC Davis Health, program directors have implicit preferences for students from schools that rotate through their sites. This creates a structural advantage for UC graduates that UOP and WesternU students work against — not a written policy but a documented pattern. A WesternU student who excels academically and builds strong preceptor relationships can match into competitive programs, but the playing field is not level. If the specific goal is oncology PGY2 at UCSF specifically, the gap year and reapplication to UC programs is worth the consideration.
Bottom line: Apply broadly enough in the first cycle that UOP or WesternU is a genuine landing spot, not just a theoretical backup. If the full cycle produces only a UOP or WesternU acceptance, accepting and performing well in Year 1 is strategically stronger than declining and reapplying — unless the science GPA was demonstrably the bottleneck with a clear plan to fix it. The worst outcome is declining all acceptances, reapplying once, and facing the same result — having lost two years with no degree and no clear differentiator in the second application. The options above (regulatory affairs MS, clinical research MS, pharmacology PhD, reverse MS strategy) are not consolation prizes — several of them lead to the same career destinations with less debt and no licensing exam.
Part 6 — If You Attend OSU, UW, or UA: Tradeoffs for Practicing in California
The short answer: California licensure is fully achievable from any of these three programs, but the path is not automatic and there are real friction points. The nature and severity of those friction points depends heavily on what kind of California pharmacy career you're targeting. A staff pharmacist at Kaiser faces almost none of them. A candidate for oncology PGY2 at UCSF faces real structural headwinds. Everything in between falls on a spectrum.
① Licensing Friction
California has no reciprocity with OR, WA, or AZ. Every graduate must pass the CPJE — California's pharmacy jurisprudence exam — regardless of where their PharmD was earned. Out-of-state programs do not teach CA pharmacy law, so self-study is required after graduation.

This adds weeks to a few months between graduation and CA licensure while the CPJE is scheduled and passed. It is a logistical friction point, not a career obstacle — most prepared candidates pass on the first attempt. But plan for the gap; you cannot practice in California until it's done.
② Rotation Year Pipeline
Most pharmacists land their first job or residency through APPE rotation connections in Year 4. An OSU student rotates in Oregon. A UW student rotates through Seattle. Those are where preceptors meet candidates and where informal offers originate.

A student who rotates entirely out of state and then applies to California positions is competing against candidates who rotated through California hospitals. Mitigation: proactively request California APPE sites in Year 4. OSU, UW, and UA all have rotation networks that extend into California — especially the Bay Area and Southern California. This requires active planning and is not guaranteed, but it substantially closes the gap.
③ Residency Match Disadvantage
California's ASHP-accredited residency programs — especially UCSF, UCLA, Cedars-Sinai, Stanford, UC Davis Health — have large local applicant pools from UCSF, UCSD, USC, and UCI. Out-of-state graduates compete against candidates whose preceptors know program directors personally.

This is the most substantive real-world impact for this profile. A strong UW graduate with Franz lab research and targeted CA rotations in Year 4 is competitive — UW's national reputation is close enough to the UC mid-tier that the disadvantage is small. For OSU and UA graduates, the path is harder but not closed: strong academic performance and proactive relationship-building with CA preceptors during APPEs can overcome the gap. It just isn't an equal playing field.
CA Practice Impact by School & Role Type
School CA Licensure
(CPJE required)		 Staff / General
Hospital Roles		 CA PGY1
Residency		 Competitive PGY2
(UCSF/UCLA/Stanford)		 Industry /
Pharma (Bay Area)
UW (Seattle) Self-study CPJE ✓ No disadvantage ✓ Competitive Small headwind ✓ No disadvantage
OSU (Corvallis) Self-study CPJE ✓ No disadvantage Manageable w/ CA APPEs Real headwind ✓ No disadvantage
U Arizona Self-study CPJE ✓ No disadvantage Manageable w/ CA APPEs Real headwind ✓ No disadvantage
What Doesn't Change — Same Outcome as CA Programs
Full ACPE accreditation — identical licensure eligibility. Same NAPLEX + CPJE path, same license, same prescriptive authority. Access to ASHP residency match system. Entry-level clinical pharmacist market at Kaiser, VA, Sutter, Dignity Health, community hospitals. Same starting salary in equivalent roles ($125–155k). Staff pharmacist, ambulatory care, specialty pharmacy, and most hospital roles. Ability to earn California licensure regardless of where the PharmD was earned. For staff pharmacist positions, employers evaluate licensure and interview — not which ACPE school you attended. Industry and regulatory affairs hiring at Bay Area pharma companies (Genentech, Gilead, AstraZeneca) is credential- and experience-driven: the PharmD is what matters, not the institution.
What You May Lose vs. a CA Program
California rotation networks at UCSF, Stanford, UCLA academic medical centers — these require explicit Year 4 planning if attending OOS. Implicit preceptor familiarity advantage for competitive PGY2 slots at CA academic programs. Alumni network depth in CA hospital systems for senior clinical specialist and academic roles. Residency program director name recognition that UC graduates carry automatically. Note on OSU specifically: OSU's 96.2% NAPLEX rate is better than every CA private school on this list including WesternU. For staff pharmacist and industry roles in CA, an OSU graduate with that licensure exam outcome is not a lesser candidate — they're often stronger on the metric that matters most.
Year 4 Mitigation Strategy (applies to OSU, UW, UA): When selecting APPE sites, prioritize California sites explicitly and early — specifically UC Davis Health, UCSF-affiliated community sites, Kaiser Northern California, VA Palo Alto, or any Bay Area academic medical center. Request these in your first or second rotation preference submission. Combine this with Franz lab research continuing into Year 3 or Year 4 if possible — a pharmacist-scientist with research credentials and a CA APPE rotation year competes on near-equal footing with UC PharmD graduates for most California clinical roles. The gap that remains is narrow and concentrated at the very top of the CA PGY2 residency market.
Verdict by school for CA practice: OSU — fully viable for CA general practice. CPJE required. Request CA APPEs. NAPLEX outcomes are genuinely superior to CA private schools; for staff and industry roles, no meaningful disadvantage. Competitive PGY2 at UCSF/Stanford is harder but not closed with a CA APPE year and Franz lab research. UW — strongest OOS option for CA return, especially for competitive residency goals. National research reputation means UW graduates are recognized by CA program directors. CPJE required, out-of-state tuition is the main cost consideration. UA — fully viable for CA general practice and industry roles. CPJE required. More accessible admission, lower out-of-state tuition than UW. Best used as a safety where return to CA is the plan and the career goal is staff pharmacist, ambulatory care, or Bay Area pharma — not competitive academic medical center residency specifically.
Prerequisite Satisfaction at Application Submission — All 9 Schools
This table answers the operational question: which requirements are fully satisfied at the moment of application (Summer 2027), and which are being fulfilled in-progress? Most PharmD programs allow prerequisites to be in-progress at application as long as they are completed before matriculation (July–August 2028). One item — NPB 101L — is submitted in-progress and must be flagged on the application.
✓ Complete before submission ⚠ In-progress at submission; complete before matriculation — Not required by this school ! Verify annually / known ambiguity
Prerequisite UC Davis Course Done By UCSF UCSD USC UCI UOP WesternU OSU UA UW Verification Notes
General Chemistry + lab CHE 2A/2B/2C + labs Spr'26 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ Universal requirement. Satisfied across all 9.
Organic Chemistry + lab CHE 118A/B/C + CHE 118L Spr'26 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ Verify UCSF approved course list accepts CHE 118 lab specifically.
General Biology + lab BIS 2A/2B/2C + labs Spr'26 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ UCSD requires cell/mol bio with lab — BIS 2C satisfies.
Human Physiology NPB 101 Fal'26 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ Satisfies physiology req at all 9. Confirm course equivalency database for each school.
Physiology Lab ⚠ NPB 101L Fal'27 — ⚠ — — ⚠ — — — — Only in-progress item at submission. UCSD + UOP require physiology lab; both permit in-progress prereqs completing before matriculation (Jul 2028). Must flag on application.
Biochemistry (upper-div) BIS 102 Fal'26 ✓ ✓ ✓ 4yr ✓ ✓ ✓ ✓ ✓ ✓ USC requires upper-div at 4-year institution — BIS 102 at UC Davis explicitly satisfies. Also fills UCSD's 1-of-3 slot.
Microbiology ⚠ lab MMG 102 Spr'27 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ Timing risk: finishes Spr'27, one quarter before submission. Confirm MMG 102 includes lab component — most common accidental omission for pre-pharm students.
Anatomy EXB 106/106L Win'27 pref. ✓ (1of3) — — — — req. — — UCSF: strongly preferred, not hard required. UCSD: 1-of-3 slot (also covered by BIS 102 and MMG 102). OSU: required — confirm EXB 106 equivalency accepted. Verify CC backup accepted if needed.
Physics ⚠ lab? PHY 007A (lab TBD) Spr'26 ✓ ✓ ✓ rec. ✓ ⚠ +lab ✓ ✓ ✓ ✓ PHY 007A confirmed Spring 2026. Algebra-based accepted at all programs. Lab is integrated into PHY 007A per UC Davis catalog (Discussion/Laboratory 5 hrs/wk) — no separate PHY 007AL exists or is needed. UOP physics + lab requirement satisfied. USC: recommended only.
Statistics STA 13 or equivalent Prior ✓ ✓ — ✓ — — ✓ ✓ ✓ Note: PharmCAS may classify statistics as math (BCPM) depending on course prefix — confirm audit classification.
English / Writing (×2) UWP 1 + UWP 104 Spr'27 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ UCSF requires two writing courses as part of its 19-unit behavioral/social science block.
Public Speaking ⚠ timing CMN 1 Spr'27 ✓ ✓ ✓ ✓ ✓ — ✓ ✓ ✓ Timing risk: finishes Spr'27, one quarter before submission — same as MMG 102. Verify CMN 1 is accepted by each school's course equivalency tool; some require explicit "oral communication" designation.
Calculus / Pre-Calc MAT 16A or equivalent Prior ✓ — — — — — — — — UCSF only. Satisfied by prior coursework.
Social / Behavioral Sciences ASA 002 (Spr'26) + ECN 001A (Spr'26) + PSC 001 (Fal'26) + SOC 001 (Fal'26) Fal'26 ✓ 19u ✓ PSC1 — — — — — — — UCSF: 19-unit behavioral/social block. ASA 002 (Spr'26) + ECN 001A (Spr'26) + PSC 001 (Fal'26) + SOC 001 (Fal'26) = 16 units — confirm whether MGT 012Y (Win'26) counts toward remaining 3 units, or add one GE in a light quarter. UCSD: PSC 001 (Fal'26) satisfies human behavior requirement — confirm on UCSD equivalencies page.
11
Prereq categories complete
before submission
1
In-progress at submission
(NPB 101L — done Fal'27)
2
Last-quarter timing risks
(MMG 102 + CMN 1, Spr'27)
Critical path note: MMG 102 and CMN 1 both complete Spring 2027 — the quarter immediately before application submission. If either enrollment is disrupted (wait-list, conflict, capacity), there is no buffer quarter remaining before the application window opens. Pre-register for both courses as early as possible. CMN 1 in particular fills quickly. If CMN 1 cannot be taken Spring 2027, it must be taken Summer 2027 (possible but creates tension with application finalization) or confirmed as acceptable while in-progress.
Spring 2027 Go / No-Go Decision Framework
Spring 2027 is the last actionable decision point before applications open. Pull your actual numbers at the end of Spring 2027 and run them through the framework below. This is the moment where you confirm portfolio strategy, expand safeties if needed, or make the call to delay one cycle. Do not wait until Summer 2027 to do this analysis.
Your Spring 2027 Inputs — Fill These In
Cumul GPA
___.__
Target ≥ 3.65
Science GPA
___.__
Target ≥ 3.50
Pharm Hours
____
Target ≥ 180
Research Status
Active / Pending
/ Paused
Decision Logic
Gate 1 — Science GPA ≥ 3.55
If yes: UCSF and UCSD are worth applying. Apply full 9-school portfolio as planned. Research background meaningfully compensates for GPA at the upper tier.
If 3.45–3.54: Drop UCSF from active strategy. Apply UCSD but recalibrate expectations to long-shot. Expand safeties — add Touro CA and CNUCOP to floor the portfolio. Match tier (USC, UCI, OSU) becomes the realistic ceiling.
If below 3.45: Trigger Scenario 3 response. Strong case for delaying one year. Evaluate post-bacc options before proceeding. See Stress Test section.
Gate 2 — Cumulative GPA ≥ 3.60
If yes: All 9 schools are valid targets at their respective tiers. No adjustments to tier strategy needed beyond Gate 1.
If 3.50–3.59: USC and UCI remain competitive. Safeties (UOP, WesternU, UA) remain strong. Trajectory narrative in personal statement becomes more important — frame the arc, not just the number.
If below 3.50: Consult with HPA advisor before submitting. A cumulative below 3.5 combined with a science GPA below 3.45 is a strong signal to delay rather than submit a weak application.
Gate 3 — Pharmacy Hours ≥ 150
If yes: Minimum threshold met. 180–200 hours in hand by application is the target. If hours are primarily hospital or clinical, 150 is sufficient. If primarily retail, 200+ is stronger for UCSF/UCSD holistic review.
If 100–149: Submit but increase hours aggressively through Summer 2027 before final application. Frame quality of experience over raw count in personal statement.
If below 100: Real gap for UCSF and UCSD. Safeties remain viable. Consider whether delaying submission and accumulating to 200+ hours by a later cycle improves overall package.
Gate 4 — Franz Lab Status
Active with ongoing contribution: strong. Include any posters, conference presentations, or manuscript status in personal statement — even "manuscript in preparation" is meaningful.
Paused or concluded: describe what you contributed and what you learned. A concluded research experience that produced a clear intellectual contribution still differentiates.
Never initiated or minimal: this removes the primary differentiator at holistic schools. Does not preclude admission at match/safety tier, but materially weakens the UCSF/UCSD case. No recovery path at this stage — proceed with realistic tier expectations.
Spring 2027 Outcome → Application Strategy
✓ All Gates Clear
Apply 9-school portfolio as planned. UCSF/UCSD worth the application fee. Submit July–August after Winter grades post. Research narrative is your top differentiator — lead with it.
⚠ One Gate Amber
Apply but adjust. Add 1–2 safeties (Touro, CNUCOP). Drop or de-prioritize UCSF based on sci GPA. Strong trajectory narrative required. Still a viable cycle.
✗ Gate 1 or 2 Red
Seriously evaluate delaying one year. A focused gap year with targeted post-bacc coursework, pharmacy hours to 350+, and a rebuilt personal statement produces a stronger application than a weak first attempt.
Personal Statement Architecture Guide
The PharmCAS personal statement is 4,500 characters (~700 words). It is read by every school you apply to. Most programs at the top tier also ask for supplemental essays — school-specific "why us" and "describe your research" prompts. The architecture below applies to the primary essay; supplement strategy is school-specific.
Structural Arc — Primary PharmCAS Essay
1
Hook — A specific moment, not a broad statement (~75 words)
Open with a concrete scene from your pharmacy work or research — not "I have always wanted to help people." The scene should reveal something specific about why pharmacy and not medicine, nursing, or research alone. Your hook should make a reader stop scrolling. For this profile: a moment in the pharmacy where you noticed a gap that pharmacist-scientist training could address is natural and distinctive.
2
Pharmacy Experience Thread — Depth, not breadth (~150 words)
Don't list your hours. Pick one or two specific observations from your pharmacy technician work that shaped your understanding of pharmacist scope. What did you see a pharmacist do that a physician couldn't, or wouldn't? What did you see go wrong when clinical knowledge was thin? The goal is to show that your hours produced an intellectual transformation, not just a time commitment. Hospital or clinical experience carries more narrative weight than retail — if you have both, lead with the clinical moment.
3
Research Thread — Translate for a non-research reader (~150 words)
This is your differentiator. Most PharmD applicants have none. Explain your Franz lab work in one plain sentence — what question does the lab ask, what is your role, what have you learned. Then connect it explicitly to pharmacy: why does this science matter for patient care or drug development? Don't assume the reader knows your lab's field. For UCSF and UCSD supplementals, you will go deeper — but in the primary essay, make it accessible and bridge it clearly to the PharmD motivation. "Manuscript in preparation" or "poster presented at X" is worth mentioning briefly if true.
4
Why PharmD Now — The integration paragraph (~150 words)
This is the paragraph most essays skip or handle weakly. Why pharmacy and not medicine, research, or PA? The answer for this profile is clear: you want to be at the interface of drug science and patient care — the pharmacist-scientist role is the only one where the NPB-level mechanistic training and clinical practice coexist. Make that explicit. Why now, after your specific trajectory? The NPB major, the lab, the pharmacy work — they converge toward this degree specifically, not generically toward "healthcare." Avoid the phrase "make a difference." Name a specific role or setting you want to work in — oncology pharmacy, industry, academic medical center clinical pharmacist. Specificity signals maturity.
5
Closing — Forward-looking, not summative (~100 words)
Don't end with "I am excited for the opportunity to contribute to your program." End with where you want to be in 10 years and what step this degree is toward that goal. One sentence of genuine specificity about the PharmD's role in your arc is worth more than two paragraphs of generic enthusiasm. If applying to UCSF specifically: they respond to pharmacist-scientist and clinical research integration — name it. For OSU and UA safeties, the closing can be more general but still forward-looking.
Common Mistakes — What to Avoid
Opening with a patient story cliché. "When my grandmother was ill..." or "I watched a pharmacist save a life..." are the two most common openings. Readers are desensitized. Open with something you actually observed, specific to your work.
Burying the research. Franz lab is the single strongest differentiator in this application. If it appears in paragraph four after three paragraphs of generic motivation, it will not do the work it should. Mention it early or weave it in by paragraph two.
Not explaining why pharmacy versus medicine. NPB majors with research experience are also strong medical school candidates. If you don't address this explicitly, readers at UCSF and UCSD will wonder. A brief, honest answer — the pharmacist's clinical depth in drug mechanism, the non-physician autonomy — is all that's needed.
Addressing a difficult quarter preemptively without prompting. Do not explain a B or a difficult semester in the primary essay unless you hit Scenario 2 or 3. If your science GPA dipped, address it in a supplemental addendum only if schools provide space for it — and frame what changed, not why it happened.
School-Specific Emphasis
UCSF: Research integration and pharmacist-scientist identity. UCSF trains clinician-scientists — they want to see that you understand that distinction and are explicitly pursuing it. Name the pharmacist-scientist track in your UCSF supplemental. Franz lab is the strongest credential you have for this school.
UCSD: Science depth and intellectual curiosity. UCSD's program emphasizes molecular and translational pharmacology. Show that you understand what makes their curriculum scientifically distinctive. Research background maps well here — go slightly more technical than the primary essay allows.
USC / UCI: Leadership, community, and communication. These programs weight interpersonal and leadership qualities alongside academic record. Foreground your ability to explain complex information to patients and colleagues — your pharmacy technician experience is directly relevant here.
OSU / UA / UW: Broad clinical preparation and professional commitment. These programs are less focused on research prestige in their admissions. Your research background still differentiates, but lead with your clinical pharmacy interest and professional development arc. Tailor the closing paragraph to each program's stated mission.
Letter of Recommendation Strategy
Most programs require 2–3 letters. The standard combination is one pharmacist supervisor letter and one to two science faculty letters. At holistic-review schools (UCSF, UCSD), letter quality and specificity are differentiating factors. A generic letter from a faculty member who barely knows you is weaker than a detailed letter from a pharmacist who supervised 150+ hours of direct work. Start building these relationships now — not Spring 2027.
Who to Ask — and When
Writer 1 — Pharmacist Supervisor
The highest-value letter for almost every program. Start cultivating this relationship from your first shift. Explicitly ask your supervisor to be your LOR writer by Spring 2026 — give them 14+ months before letters are due. A pharmacist who has supervised your clinical judgment, patient interaction, and professional comportment for 150+ hours can write specifics that a faculty member cannot.
Ask by: Spring 2026
Writer 2 — Franz Lab PI or Supervisor
Your research supervisor is the second most valuable letter for UCSF and UCSD specifically. A letter from a PI who can describe your intellectual contributions, your ability to handle ambiguity, and your scientific maturity is the single most differentiating letter in a PharmD application pool where most applicants have no research. Confirm your PI is willing to write for you by Fall 2026.
Ask by: Fal'26
Writer 3 — Science Faculty (knows you)
This should be a faculty member from one of your hard BCPM courses who has seen your work specifically — not just your grade. Office hours attendance, asking good questions, doing well on exams is not enough. If possible, identify a faculty member whose course prompted a genuine intellectual exchange or whose research area connects to your interests. Quality over prestige of the writer's title.
Identify by: Win'27
What to Give Your Writers — The LOR Packet
When you formally ask someone to write, give them a packet — not just a verbal request. The packet reduces their cognitive load and dramatically increases letter specificity. Include: (1) A one-page summary of your application narrative — who you are, what you've done, what your goal is, and why pharmacy. (2) Your CV or activities summary. (3) A draft or outline of your personal statement once it exists. (4) Two or three specific things you hope they can address — for the pharmacist, this might be your clinical judgment and professional communication; for the PI, your intellectual contributions to the lab. (5) The submission deadline and the PharmCAS process for submitting letters. Make it as easy as possible for them to say yes and write well.
LOR Requirements by School
School # Letters Pharmacist Required? Notes
UCSF 3 Yes At least 1 pharmacist. Research supervisor LOR is a significant differentiator here. Holistic readers note LOR specificity carefully.
UCSD 3 Yes At least 1 pharmacist. Research LOR valued. Verify via UCSD Skaggs admissions page — requirements occasionally updated.
USC 3 Yes At least 1 pharmacist supervisor. Leadership and community involvement can be reflected in 3rd letter.
UCI 3 Yes Newer program — verify current requirements at UCI School of Pharmacy and Pharmaceutical Sciences.
UOP 3 Yes At least 1 from a pharmacist. Holistic review is less granular — letters matter less than at UCSF but still required.
WesternU 2–3 Yes Verify current requirements. Has fluctuated. At minimum 1 pharmacist.
OSU 3 Yes At least 1 pharmacist. Strong academic LOR valued. Verify OSU College of Pharmacy page annually.
UA 3 Yes At least 1 pharmacist. Rolling admissions — submit letters with or just after application.
UW 3 Yes At least 1 pharmacist. Research supervisor LOR valued at UW given their residency match rate focus.
Interview Preparation Framework
Interviews begin arriving October–December 2027 for most programs. Most programs use Multiple Mini Interviews (MMI), panel interviews, or a combination. UCSF uses MMI. UCSD uses panel. USC uses MMI. OSU uses traditional panel. Prepare for both formats but prioritize MMI practice — it requires a different skill set from traditional interview prep.
Format Guide — MMI vs Panel
Multiple Mini Interview (MMI)
6–10 stations of 6–8 minutes each. Each station has a new interviewer and a new scenario — ethical dilemma, role-play, policy question, or current events in healthcare. There is no carryover between stations. Strengths at MMI: consistency across stations, clear reasoning out loud, managing silence. The most common mistake: over-thinking the "right" answer. MMI scores ethical reasoning and communication, not knowledge recall. Practice out loud — reading sample scenarios silently does not prepare you for speaking under time pressure. Used by UCSF, USC, OSU, UA.
Panel / Traditional Interview
2–4 interviewers, 30–60 minutes. Expect behavioral questions (tell me about a time when...), motivation questions (why pharmacy, why this program), and occasionally current pharmacy policy questions. UCSD, UOP, and some supplemental rounds at USC use panel or hybrid formats. Prepare structured STAR-format answers (Situation, Task, Action, Result) for behavioral questions. Know your application inside out — interviewers often open the interview with questions about specific items on your PharmCAS application. Your research will come up; practice explaining it in 90 seconds for a non-specialist.
What Each School Probes For
UCSF: Research integration, pharmacist-scientist identity, systems thinking. They want to understand if you can hold both the science and the clinical perspective simultaneously. Expect a station or question about your research — be ready to explain what question the lab asks and why it matters for patient care, in two minutes, to a reader with no neuroscience background.
UCSD: Scientific depth and intellectual honesty. UCSD interviewers often probe with follow-up questions to test the depth behind your answer — not to trick you but to see how you think when pushed. If you don't know something, say so directly and reason from what you do know. Intellectual confidence under uncertainty scores better than confident wrong answers.
USC / UCI: Communication, leadership, and patient-centeredness. These programs place weight on interpersonal competency. Your pharmacy technician experience is directly relevant — have a story ready about a difficult patient interaction or a moment where clear communication changed an outcome. Role-play stations at USC MMI often involve patient communication scenarios.
OSU / UA / UW: Professionalism, interpersonal skills, and practical pharmacy knowledge. Traditional panel format favors clear, composed answers with specific examples. Know why you chose out-of-state — have a confident answer for "why OSU / why UW / why UA" that doesn't imply these are your safety choices. Each school wants to enroll students who genuinely want to be there.
Explaining Franz Lab Research to Interviewers
Prepare two versions. Short version (60–90 seconds): One sentence on what the lab studies, one sentence on your specific role, one sentence on what you've learned, and one sentence on why it connects to pharmacy or patient care. This is for most panel and MMI stations. Deep version (3–4 minutes): Same structure but with more mechanistic detail — for UCSF and UCSD interviewers who will push for depth. Practice the transition between versions — interviewers will often start with "tell me about your research" and then either let you continue (deep version) or redirect (short version). Do not assume they want the full story unless they keep asking.
If Asked About a Difficult Quarter
If Winter 2027 produced grades below your projected range and an interviewer asks about the dip: answer honestly, briefly, and forward. Do not over-explain or apologize. The structure that works: acknowledge the quarter directly ("Winter 2027 was my hardest quarter — three BCPM courses simultaneously"), name what you learned or changed ("I adjusted my approach to..."), and pivot to what came next ("the following quarter I returned to..."). Interviewers are evaluating self-awareness and resilience, not the grade itself. A composed, honest answer about a difficult quarter scores better than avoidance or excessive explanation.
Financial Comparison — 4-Year Cost & Debt-to-Income Analysis
The strategic analysis throughout this document focuses on admission odds. But the financial reality of each acceptance matters equally when choosing between offers in Winter–Spring 2028. Total program cost varies by more than $100,000 across this list. At pharmacist starting salaries of $125–155k, that difference can represent 1–2 years of post-tax income before any loan interest is counted.
Figures are estimates based on 2025–26 published tuition rates. Costs increase approximately 3–5% annually. COL = cost of living (rent, food, transport) estimated for program location. Verify current figures before making financial decisions.
School Annual Tuition Annual COL Est. 4-Yr Total Cost Scholarship / Aid Net 4-Yr Estimate Debt / Income Ratio* Notes
UCSF ~$38,000 ~$30,000 ~$272,000 Merit-based; limited ~$250–272k 1.7–1.9× State school tuition but SF cost of living is highest in list. UCSF prestige justifies premium only for specific residency/academic career goals.
UCSD ~$36,000 ~$26,000 ~$248,000 Merit-based; limited ~$230–248k 1.5–1.7× La Jolla COL lower than SF. Strong program at a meaningfully lower total cost than UCSF.
USC ~$60,000 ~$24,000 ~$336,000 Merit possible; limited ~$300–336k 2.0–2.3× Highest tuition in list. Strong LA alumni network but debt load is significant. Compare carefully vs UCSD if both admit.
UCI ~$37,000 ~$24,000 ~$244,000 Merit-based; newer program ~$220–244k 1.4–1.7× UC tuition. Newer program may offer merit aid to attract strong students. Best value among CA programs at this tier.
UOP ~$54,000 ~$20,000 ~$296,000 Merit possible ~$270–296k 1.8–2.0× High private tuition for a safety-tier school. Use as floor only. If UOP is the only acceptance, evaluate financially vs gap year.
WesternU ~$52,000 ~$22,000 ~$288,000 Merit possible ~$265–288k 1.7–1.9× Similar financial profile to UOP. Safety value is as a floor for portfolio probability, not as a financially preferred outcome.
OSU ★ ~$34,000 (-$19k schol.) ~$18,000 ~$208,000 $19k/yr auto (GPA ≥3.0) ~$140–160k net 0.9–1.1× Best financial value in list by a wide margin. Net cost with scholarship approaches in-state UC tuition. 96.2% NAPLEX. If admitted here and at a CA private (USC, UOP, WesternU) — OSU wins the financial comparison unambiguously.
UA ~$30,000 ~$16,000 ~$184,000 Merit possible ~$160–184k 1.0–1.2× Lowest total cost in list. Tucson COL is substantially below CA/OR. If career goal is staff pharmacist or industry (not competitive CA residency), the financial case for UA is strong.
UW ~$45,000 ~$24,000 ~$276,000 Limited for OOS ~$250–276k 1.6–1.8× High OOS tuition without the automatic scholarship OSU provides. National reputation justifies cost premium over UA/OSU only if competitive CA residency is the specific goal.
OSU vs. USC — The Comparison That Matters Most
If admitted to both USC and OSU, the financial differential is approximately $160,000–180,000 over four years after OSU's scholarship. At a $140k starting salary with 25% effective tax rate, that differential is 1.5–2 years of take-home income before interest. For a career goal of staff pharmacist or Bay Area industry, USC's name recognition advantage over OSU is minimal and does not justify that cost differential. The case for USC over OSU only strengthens if USC provides significant merit aid or if the LA network is specifically critical to your residency goal.
When UCSF's Premium Is Justified
UCSF's debt load (~$250k) is justifiable if the career goal specifically requires the UCSF brand — oncology PGY2 at a top-5 CA academic medical center, PharmD/PhD dual degree, or a faculty/research pharmacist career at an academic institution. For a clinical pharmacist at Kaiser or a Bay Area pharma industry role, UCSF at $250k versus OSU at $150k is a $100k premium for a credential advantage that doesn't exist in those hiring contexts. Run the numbers for your specific career goal before automatically preferring the most prestigious acceptance.
*Debt/Income Ratio calculated as estimated net 4-yr cost divided by $145k (midpoint of $125–155k starting salary range). Excludes undergraduate debt. Does not account for interest, income growth, or PSLF eligibility.
What To Do Right Now — 30-Day Action Sprint
This document covers 2026–2028 comprehensively. But reading it in February 2026, the most pressing question is: what do I do in the next 30 days? Below is a prioritized sprint list — items ranked by urgency and consequence of delay. None of these require waiting.
This Week — Do Before Anything Else
1
Schedule your NPB advisor meeting
Confirm the NPB + Electives track, verify which courses count toward degree, and get the sequencing locked. This meeting is the foundation for every other decision in this document.
This week
2
Schedule your HPA (Health Professions Advising) appointment
HPA advisors have school-specific PharmD knowledge, can confirm prerequisite equivalencies, and can review your overall plan. These appointments fill up — book now for Spring 2026.
This week
3
Update your resume
NPB major, Organic Chemistry complete, Franz lab research, PharmD goal clearly stated. You will need this for pharmacy tech job applications immediately and for LOR writer packets later.
This week
Week 2 — High Priority
4
Start CA Pharmacy Technician license application (PTCB route)
The licensing process takes weeks. Starting now means you can begin paid technician work by April or May 2026, which is critical for accumulating 180+ hours before the Summer 2027 application window.
Week 2
5
Email UCSF and UCSD admissions about anatomy equivalency
Specifically ask whether EXB 106 at UC Davis satisfies their anatomy preference and whether a community college anatomy course (Ohlone BIOL 231 or Foothill BIOL 40A) would be accepted as a backup. Get answers in writing — not phone, email. This removes a potential single point of failure before it can become one.
Week 2
6
Create your PharmCAS account
You won't submit until Summer 2027, but creating the account now lets you run the GPA estimator with your current transcripts and see exactly where the PharmCAS calculation lands. This is the single most important number in this entire plan — know it early and update it each quarter.
Week 2
Weeks 3–4 — Important but Less Urgent
7
Apply to 8–10 pharmacy technician positions
Prioritize Kaiser Fremont, UC Davis Health, and hospital pharmacies over retail — both for the quality narrative and for the supervision you'll need for a strong LOR. Include Walgreens or CVS only as fallbacks if hospital positions don't come through quickly.
Weeks 3–4
8
Have a direct conversation with your Franz lab PI
Confirm your research role through at least Fall 2026 and whether there is a realistic path to a poster, conference presentation, or manuscript contribution before application submission. You don't need to ask about LOR yet — that comes Fall 2026 — but knowing your lab trajectory now shapes how you describe research in your personal statement.
Weeks 3–4
9
Verify CMN 1 Spring 2026 enrollment capacity
CMN 1 fills quickly. If it's not accessible Spring 2026, it moves to Spring 2027 — which creates the timing risk flagged in the prerequisite table. Check availability now and register during your earliest enrollment window.
Weeks 3–4
10
Pre-register for a CC anatomy backup course
Identify and register (even if you later drop) for a community college anatomy course as a contingency. Ohlone BIOL 231 or Foothill BIOL 40A are the recommended options. This costs nothing to hold and eliminates the enrollment risk for EXB 106.
Weeks 3–4
Glossary — Key Terms & Concepts
Definitions for technical terms used throughout this document. Grouped by category. Where a term's meaning differs from common usage, the document-specific sense is noted.
Admissions Systems & Processes
PharmCAS
Pharmacy College Application Service. The centralized application portal used by most U.S. PharmD programs. Calculates its own standardized GPA independently of your institution's transcript, recalculating all coursework — including transferred units — on a uniform 4.0 scale. This is the GPA admissions committees actually see, not your UC Davis transcript GPA.
PharmCAS GPA
The cumulative GPA PharmCAS recalculates from all college transcripts submitted. Includes all graded coursework from every institution attended (UC Davis, Mission College, Ohlone, etc.). AP credit and P-grade courses are excluded. Can differ meaningfully from your UC Davis institutional GPA. Run the PharmCAS GPA estimator at help.liaisonedu.com before submitting.
BCPM (Science GPA)
Biology, Chemistry, Physics, Math. The subset of your PharmCAS GPA covering only science and math coursework, evaluated separately from cumulative GPA. Psychology, economics, writing, and social science do not count. Final course classification is determined by PharmCAS audit and can differ from how your institution categorizes a course — some statistics and neuroscience courses have been reclassified in past audits.
Holistic Review
An admissions evaluation process that considers the full application profile beyond GPA — pharmacy experience, research, personal statement, letters of recommendation, and interview performance. UCSF and UCSD use holistic review after an initial GPA screen; UOP and WesternU rely more heavily on quantitative sorting. Above the GPA threshold, holistic factors do most of the differentiating at top-tier programs.
Rolling Admissions
An application review process where schools evaluate and issue admissions decisions as files arrive rather than waiting for a single deadline. Submitting early in the cycle meaningfully increases odds — early applicants are reviewed against a less competitive pool and remaining seats decrease over time. Relevant for match and safety schools especially.
PharmD
Doctor of Pharmacy. A four-year professional degree required for pharmacy licensure in the United States. Distinct from a PhD in pharmaceutical sciences — the PharmD is a clinical practice credential, not a research degree. All programs on this list are ACPE-accredited, meaning graduates have identical federal and state licensure eligibility regardless of which school awarded the degree.
Licensing & Examinations
NAPLEX
North American Pharmacist Licensure Examination. The standardized national competency exam required for pharmacy licensure in all U.S. states. Taken after PharmD graduation. First-attempt pass rate is a meaningful program quality indicator — OSU's 96.2% rate (2024, ranked #5 nationally) exceeds every California private school on this list, and is cited as the primary evidence for OSU's value proposition.
CPJE
California Pharmacy Jurisprudence Examination. California-specific exam covering state pharmacy law. Required for California licensure regardless of where the PharmD was earned — California has no reciprocity with Oregon, Washington, or Arizona. Out-of-state graduates must self-study CA law after graduation. This is a logistical friction point (weeks to months of delay), not a career obstacle for prepared candidates. Most pass on the first attempt.
ACPE
Accreditation Council for Pharmacy Education. The national body that accredits PharmD programs. All schools on this list are ACPE-accredited. ACPE accreditation means graduates have identical federal licensure eligibility and can sit for NAPLEX in any state — the accrediting institution does not confer an advantage or disadvantage for basic licensure purposes. What differs across schools is residency network strength, NAPLEX outcomes, and clinical rotation access.
Residency & Clinical Training
APPE
Advanced Pharmacy Practice Experience. The fourth-year clinical rotation year of a PharmD program, where students rotate through hospital, ambulatory care, and specialty pharmacy settings. APPE site location heavily influences where graduates network for jobs and residencies — preceptors meet candidates informally and often extend first opportunities here. For out-of-state students planning to practice in California, proactively requesting California APPE sites in Year 4 is the primary mitigation strategy for the network disadvantage.
PGY1 Residency
Post-Graduate Year 1 residency. A one-year accredited training program in general pharmacy practice completed after PharmD graduation. Optional but increasingly expected for hospital clinical pharmacist and specialist roles. Competitively matched through the ASHP Match system (similar to the medical residency Match). California PGY1 programs have large local applicant pools from UCSF, UCSD, USC, and UCI.
PGY2 Residency
Post-Graduate Year 2 residency. A one-year specialty training program (oncology, critical care, infectious disease, etc.) completed after PGY1. Highly competitive at top programs. UCSF, UCLA, Stanford, and Cedars-Sinai draw primarily from candidates who rotated through California academic medical centers. For this profile, the oncology PGY2 pathway at a CA academic center is the career goal most sensitive to school choice — out-of-state graduates face a real but not insurmountable headwind.
ASHP
American Society of Health-System Pharmacists. Administers the national pharmacy residency matching program. ASHP-accredited residency programs are the standard pathway to clinical specialist careers. Residency match rates vary by program — UW's 93% match rate (Class of 2025) and OSU's strong NAPLEX outcomes are used in this document as evidence of training quality beyond the basic PharmD credential.
Application Strategy Terms
Reach / Match / Safety
Tier classification used throughout this document. Reach: admission possible but not probable even at projected GPA (UCSF, UCSD). Match: profile is competitive with meaningful acceptance odds (USC, UCI, UW, OSU). Safety: profile significantly exceeds the median admitted applicant — acceptance likely but not guaranteed if interview is obtained (UOP, WesternU, UA). No school is a certain acceptance.
Portfolio Probability
The probability of receiving at least one acceptance across the full list of schools applied to. Mathematically distinct from per-school probability — applying to 9 schools raises portfolio probability even when each individual school's odds are modest. Importantly, school decisions are not statistically independent: a systematic application weakness tends to affect multiple schools simultaneously, so the theoretical upper bound overstates realistic odds. The safety schools (UOP, WesternU, UA) carry most of the floor for this portfolio.
LOR (Letter of Recommendation)
Required application component. Most programs require 2–3 letters, typically from a licensed pharmacist supervisor and one or more science faculty who know the applicant's work specifically. Letter quality and specificity are differentiating factors at holistic-review schools — a generic letter from a faculty member who barely knows the student is weaker than a detailed letter from a pharmacist who supervised 150+ hours of direct patient care work.
Post-Bacc Coursework
Upper-division science courses taken after the primary undergraduate degree, typically to strengthen a weak science GPA or complete missing prerequisites. Used in the Scenario 3 contingency plan — if science GPA falls below 3.45, targeted post-bacc BCPM courses at a 4-year institution can demonstrably improve the science GPA trend before reapplying. Four to six units of A-range grades in relevant upper-div science moves the needle meaningfully at these unit totals.
Execution Correlation
The concept that application weaknesses tend to co-occur rather than fail independently across schools. A difficult Winter 2027 quarter can simultaneously suppress GPA, reduce research bandwidth in Franz lab, strain faculty relationships needed for strong letters, and affect interview confidence — all in the same application cycle. This is why GPA protection matters beyond the number itself: it preserves the surrounding ecosystem of the application.
Deferral
Delaying PharmD matriculation by one year after receiving an acceptance offer. Discussed in this document as a post-acceptance option only — never as a pre-application strategy. When framing a deferral request to an admissions committee, present it as a specific professional development plan (e.g., completing a research year, gaining additional clinical exposure), not as general exploration or indecision about the field.
Coursework & Institutional Terms
NPB (Major)
Neurobiology, Physiology & Behavior. The UC Davis undergraduate major this student is completing. A critical distinction throughout this document: NPB 110A/B/C and BIS 101 are NPB major requirements but are not PharmD prerequisites at any program on this list. This distinction drives the entire course sequencing strategy — those courses are placed post-application (Fall 2027–Spring 2028), freeing up the pre-application window for courses that are both major requirements and PharmD prerequisites.
BIS Courses (UC Davis)
UC Davis Biological Sciences department course prefix. BIS 102 (Biochemistry) and BIS 103 (Bioenergetics and Metabolism) are PharmD prerequisites and BCPM-qualifying — among the highest-stakes courses in the plan. BIS 101 (Genes & Gene Expression) is an NPB major requirement only, not a PharmD prerequisite at any school on this list, and is therefore sequenced post-application.
Franz Lab
Research lab at UC Davis where this student has ongoing research involvement. Used throughout the document as the primary differentiating credential relative to a typical PharmD applicant. Research experience — and any resulting publications, presentations, or poster credits — anchors the personal statement and distinguishes this profile at holistic-review schools. The Franz lab background is what justifies applying to UCSF and UCSD as genuine reaches rather than aspirational long shots.
EXB 106 / EXB 106L
UC Davis Exercise Biology course covering human anatomy and physiology, offered with a required lab section. Functions as the anatomy prerequisite for this plan — satisfying the anatomy component of UCSD's "1 of 3" requirement (Anatomy, Microbiology, or Biochemistry). Has enrollment restrictions that may require a backup community college option (Ohlone BIOL 231, Foothill BIOL 40A). Confirm CC anatomy equivalency with UCSF and UCSD admissions in writing before relying on a CC backup.
NPB + Electives · UC Davis · PharmD Fall 2028 Entry Updated February 2026 — v12 · Click any checklist item to mark complete